<?xml version="1.0" encoding="utf-8"?>
<xbrli:xbrl xmlns="http://www.xbrl.org/2003/instance" xmlns:f="http://xbrl.dcca.dk/sob" xmlns:b="http://xbrl.dcca.dk/entryBalanceSheetAccountFormIncomeStatementByNature" xmlns:h="http://xbrl.dcca.dk/mrv" xmlns:g="http://xbrl.dcca.dk/arr" xmlns:d="http://xbrl.dcca.dk/cmn" xmlns:e="http://xbrl.dcca.dk/fsa" xmlns:c="http://xbrl.dcca.dk/gsd" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://xbrl.dcca.dk/entryBalanceSheetAccountFormIncomeStatementByNature http://archprod.service.eogs.dk/taxonomy/20211001/entryDanishGAAPBalanceSheetAccountFormIncomeStatementByNatureIncludingManagementsReviewStatisticsAndTax20211001.xsd">
  <link:schemaRef xlink:type="simple" xlink:href="http://archprod.service.eogs.dk/taxonomy/20211001/entryDanishGAAPBalanceSheetAccountFormIncomeStatementByNatureIncludingManagementsReviewStatisticsAndTax20211001.xsd" />
  <c:InformationOnTypeOfSubmittedReport contextRef="c1">Årsrapport</c:InformationOnTypeOfSubmittedReport>
  <c:NameAndSurnameOfChairmanOfGeneralMeeting contextRef="c1">Ulrik Bayer</c:NameAndSurnameOfChairmanOfGeneralMeeting>
  <c:DateOfGeneralMeeting contextRef="c1">2023-04-11</c:DateOfGeneralMeeting>
  <d:TypeOfAuditorAssistance contextRef="c1">Revisionspåtegning</d:TypeOfAuditorAssistance>
  <e:ClassOfReportingEntity contextRef="c1">Regnskabsklasse C, mellemstor virksomhed</e:ClassOfReportingEntity>
  <c:NameOfSubmittingEnterprise contextRef="c1">Beierholm</c:NameOfSubmittingEnterprise>
  <c:AddressOfSubmittingEnterpriseStreetAndNumber contextRef="c1">Voergaardvej 2</c:AddressOfSubmittingEnterpriseStreetAndNumber>
  <c:AddressOfSubmittingEnterprisePostcodeAndTown contextRef="c1">9200 Aalborg SV</c:AddressOfSubmittingEnterprisePostcodeAndTown>
  <c:PrecedingReportingPeriodStartDate contextRef="c1">2021-01-01</c:PrecedingReportingPeriodStartDate>
  <c:PredingReportingPeriodEndDate contextRef="c1">2021-12-31</c:PredingReportingPeriodEndDate>
  <c:ReportingPeriodStartDate contextRef="c1">2022-01-01</c:ReportingPeriodStartDate>
  <c:ReportingPeriodEndDate contextRef="c1">2022-12-31</c:ReportingPeriodEndDate>
  <c:IdentificationNumberCvrOfReportingEntity contextRef="c1">39024705</c:IdentificationNumberCvrOfReportingEntity>
  <c:NameOfReportingEntity contextRef="c1">STENOCARE A/S</c:NameOfReportingEntity>
  <c:AddressOfReportingEntityStreetName contextRef="c1">Nyholmsvej</c:AddressOfReportingEntityStreetName>
  <c:AddressOfReportingEntityStreetBuildingIdentifier contextRef="c1">4</c:AddressOfReportingEntityStreetBuildingIdentifier>
  <c:AddressOfReportingEntityPostCodeIdentifier contextRef="c1">8930</c:AddressOfReportingEntityPostCodeIdentifier>
  <c:AddressOfReportingEntityDistrictName contextRef="c1">Randers NØ</c:AddressOfReportingEntityDistrictName>
  <c:RegisteredOfficeOfReportingEntity contextRef="c1">Allerød</c:RegisteredOfficeOfReportingEntity>
  <d:NameOfAuditFirm contextRef="c1027">PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB</d:NameOfAuditFirm>
  <d:IdentificationNumberCvrOfAuditFirm contextRef="c1027">33771231</d:IdentificationNumberCvrOfAuditFirm>
  <c:AddressOfAuditorStreetName contextRef="c1027">Strandvejen</c:AddressOfAuditorStreetName>
  <c:AddressOfAuditorStreetBuildingIdentifier contextRef="c1027">44</c:AddressOfAuditorStreetBuildingIdentifier>
  <c:AddressOfAuditorPostCodeIdentifier contextRef="c1027">2900</c:AddressOfAuditorPostCodeIdentifier>
  <c:AddressOfAuditorDistrictName contextRef="c1027">Hellerup</c:AddressOfAuditorDistrictName>
  <c:AddressOfAuditorCountry contextRef="c1027">Danmark</c:AddressOfAuditorCountry>
  <e:SelectedElementsFromReportingClassD contextRef="c1">true</e:SelectedElementsFromReportingClassD>
  <e:AccountingPoliciesAreUnchangedFromPreviousPeriod contextRef="c1">true</e:AccountingPoliciesAreUnchangedFromPreviousPeriod>
  <f:IdentificationOfApprovedAnnualReport contextRef="c1" xml:lang="en">We have on this day presented the annual report for the financial year  01.01.22 -  31.12.22 for STENOCARE A/S.</f:IdentificationOfApprovedAnnualReport>
  <f:ConfirmationThatAnnualReportIsPresentedInAccordanceWithRequirementsProvidedForByLegislationAnyStandardsAndRequirementsProvidedByArticlesOfAssociationOrByAgreement contextRef="c1" xml:lang="en">The annual report is presented in accordance with the Danish Financial Statements Act (Årsregnskabsloven).</f:ConfirmationThatAnnualReportIsPresentedInAccordanceWithRequirementsProvidedForByLegislationAnyStandardsAndRequirementsProvidedByArticlesOfAssociationOrByAgreement>
  <f:ConfirmationThatFinancialStatementGivesTrueAndFairViewOfAssetsLiabilitiesEquityFinancialPositionAndResults contextRef="c1" xml:lang="en">In our opinion, the financial statements give a true and fair view of the company's assets, liabilities and financial position as at 31.12.22 and of the results of the company's activities  and cash flows for the financial year 01.01.22 - 31.12.22.</f:ConfirmationThatFinancialStatementGivesTrueAndFairViewOfAssetsLiabilitiesEquityFinancialPositionAndResults>
  <f:ManagementsStatementAboutManagementsReview contextRef="c1" xml:lang="en">We believe that the management's review includes a fair review of the matters dealt with in the management's review.</f:ManagementsStatementAboutManagementsReview>
  <f:RecommendationForApprovalOfAnnualReportByGeneralMeeting contextRef="c1" xml:lang="en">The annual report is submitted for adoption by the general meeting.</f:RecommendationForApprovalOfAnnualReportByGeneralMeeting>
  <f:PlaceOfSignatureOfStatement contextRef="c1">Randers NØ</f:PlaceOfSignatureOfStatement>
  <f:DateOfApprovalOfAnnualReport contextRef="c1">2023-03-16</f:DateOfApprovalOfAnnualReport>
  <d:NameAndSurnameOfMemberOfExecutiveBoard contextRef="c73">Thomas Skovlund Schnegelsberg</d:NameAndSurnameOfMemberOfExecutiveBoard>
  <d:NameAndSurnameOfMemberOfSupervisoryBoard contextRef="c58">Marianne Wier</d:NameAndSurnameOfMemberOfSupervisoryBoard>
  <d:TitleOfMemberOfSupervisoryBoard contextRef="c58">Chairman</d:TitleOfMemberOfSupervisoryBoard>
  <d:NameAndSurnameOfMemberOfSupervisoryBoard contextRef="c59">Søren Melsing Frederiksen</d:NameAndSurnameOfMemberOfSupervisoryBoard>
  <d:NameAndSurnameOfMemberOfSupervisoryBoard contextRef="c60">Jeppe Bo Petersen</d:NameAndSurnameOfMemberOfSupervisoryBoard>
  <d:NameAndSurnameOfMemberOfSupervisoryBoard contextRef="c61">Søren Kjær</d:NameAndSurnameOfMemberOfSupervisoryBoard>
  <g:AddresseeOfAuditorsReportOnAuditedFinancialStatements contextRef="c1" xml:lang="en">To the Shareholder of STENOCARE A/S

</g:AddresseeOfAuditorsReportOnAuditedFinancialStatements>
  <g:TypeOfModifiedOpinionOnAuditedFinancialStatements contextRef="c1" xml:lang="en">Opinion</g:TypeOfModifiedOpinionOnAuditedFinancialStatements>
  <g:IdentificationOfAuditedFinancialStatements contextRef="c1" xml:lang="en">We have audited the financial statements of STENOCARE A/S for the financial year 01.01.22 - 31.12.22, which comprise the income statement, balance sheet, statement of changes in equity, cash flow statement and notes to the financial statements, including a summary of significant accounting policies. The financial statements are prepared in accordance with the Danish Financial Statements Act (Årsregnskabsloven).</g:IdentificationOfAuditedFinancialStatements>
  <g:OpinionOnAuditedFinancialStatements contextRef="c1" xml:lang="en">In our opinion the financial statements give a true and fair view of the company's assets, liabilities and financial position at 31.12.22 and of the results of the company's operations and cash flows for the financial year 01.01.22 - 31.12.22 in accordance with the the Danish Financial Statements Act (Årsregnskabsloven).</g:OpinionOnAuditedFinancialStatements>
  <g:TypeOfBasisForModifiedOpinionOnAuditedFinancialStatements contextRef="c1" xml:lang="en">Basis for Opinion</g:TypeOfBasisForModifiedOpinionOnAuditedFinancialStatements>
  <g:DescriptionOfQualificationsOfAuditedFinancialStatements contextRef="c1" xml:lang="en">We conducted our audit in accordance with International Standards on Auditing and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the “Auditor’s responsibilities for the audit of the financial statements” section of our report. We are independent of the company in accordance with the International Ethics Standards Board for Accountants’ International Code of Ethics for Professional Accountants (IESBA Code) and the additional ethical requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements and the IESBA Code. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.</g:DescriptionOfQualificationsOfAuditedFinancialStatements>
  <g:StatementOnManagementsReviewAuditorsReportOnAuditedFinancialStatements contextRef="c1" xml:lang="en">Management is responsible for management’s review.
Our opinion on the financial statements does not cover management’s review, and we do not express any form of assurance conclusion thereon. 
In connection with our audit of the financial statements, our responsibility is to read management’s review and, in doing so, consider whether management’s review is materially inconsistent with the financial statements or our knowledge obtained during the audit, or otherwise appears to be materially misstated.
Moreover, it is our responsibility to consider whether management’s review provides the information required under the Danish Financial Statements Act.
Based on the work we have performed, we conclude that management’s review is in accordance with the financial statements and has been prepared in accordance with the requirements of the Danish Financial Statements Acts. We did not identify any material misstatement of management’s review.</g:StatementOnManagementsReviewAuditorsReportOnAuditedFinancialStatements>
  <g:StatementOfExecutiveAndSupervisoryBoardsResponsibilityForFinancialStatements contextRef="c1" xml:lang="en">The Management is responsible for the preparation of financial statements that give a true and fair view in accordance with the Danish Financial Statements Act. Furthermore the Management is responsible for the internal control as the Management determines is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.
In preparing the financial statements, management is responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting in preparing the financial statements unless management either intends to liquidate the company or to cease operations, or has no realistic alternative but to do so. </g:StatementOfExecutiveAndSupervisoryBoardsResponsibilityForFinancialStatements>
  <g:StatementOfAuditorsResponsibilityForAuditAndAuditPerformed contextRef="c1" xml:lang="en">Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with International Standards on Auditing and the additional requirements applicable in Denmark will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements. 
As part of an audit conducted in accordance with International Standards on Auditing and the additional requirements applicable in Denmark, we exercise professional judgment and maintain professional skepticism throughout the audit. We also: 
Identify and assess the risks of material misstatement of the financial statements, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control.
Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the company's internal control.
Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures made by management.
Conclude on the appropriateness of management’s use of the going concern basis of accounting in preparing the financial statements and, based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the company's ability to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our auditor’s report to the related disclosures in the financial statements or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our auditor’s report. However, future events or conditions may cause the company to cease to continue as a going concern.
Evaluate the overall presentation, structure and contents of the financial statements, including the disclosures, and whether the financial statements represent the underlying transactions and events in a manner that gives a true and fair view.
We communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit. </g:StatementOfAuditorsResponsibilityForAuditAndAuditPerformed>
  <g:SignatureOfAuditorsPlace contextRef="c1">Hellerup</g:SignatureOfAuditorsPlace>
  <g:SignatureOfAuditorsDate contextRef="c1">2023-03-16</g:SignatureOfAuditorsDate>
  <d:NameAndSurnameOfAuditor contextRef="c1027">Allan Knudsen</d:NameAndSurnameOfAuditor>
  <d:DescriptionOfAuditor contextRef="c1027">State Authorized Public Accountant</d:DescriptionOfAuditor>
  <d:IdentificationNumberOfAuditor contextRef="c1027">mne29465</d:IdentificationNumberOfAuditor>
  <h:NameOfKeyFigureOrFinancialRatio contextRef="c324">Loss before depreciation, amortisation, write-downs and impairment losses</h:NameOfKeyFigureOrFinancialRatio>
  <h:ValueOfKeyFigureOrFinancialRatio contextRef="c324" unitRef="u4" decimals="INF">-13215</h:ValueOfKeyFigureOrFinancialRatio>
  <h:ValueOfKeyFigureOrFinancialRatio contextRef="c325" unitRef="u4" decimals="INF">-12992</h:ValueOfKeyFigureOrFinancialRatio>
  <h:ValueOfKeyFigureOrFinancialRatio contextRef="c326" unitRef="u4" decimals="INF">-11829</h:ValueOfKeyFigureOrFinancialRatio>
  <h:ValueOfKeyFigureOrFinancialRatio contextRef="c327" unitRef="u4" decimals="INF">4417</h:ValueOfKeyFigureOrFinancialRatio>
  <h:ValueOfKeyFigureOrFinancialRatio contextRef="c328" unitRef="u4" decimals="INF">-3591</h:ValueOfKeyFigureOrFinancialRatio>
  <e:ResultsFromNetFinancials contextRef="c12" unitRef="u2" decimals="-3">-1648000</e:ResultsFromNetFinancials>
  <e:ResultsFromNetFinancials contextRef="c15" unitRef="u2" decimals="-3">-2112000</e:ResultsFromNetFinancials>
  <e:ResultsFromNetFinancials contextRef="c18" unitRef="u2" decimals="-3">-13000</e:ResultsFromNetFinancials>
  <e:ProfitLoss contextRef="c12" unitRef="u2" decimals="-3">-11786000</e:ProfitLoss>
  <e:ProfitLoss contextRef="c15" unitRef="u2" decimals="-3">1702000</e:ProfitLoss>
  <e:ProfitLoss contextRef="c18" unitRef="u2" decimals="-3">-3276000</e:ProfitLoss>
  <h:NameOfKeyFigureOrFinancialRatio contextRef="c349">Sales</h:NameOfKeyFigureOrFinancialRatio>
  <h:ValueOfKeyFigureOrFinancialRatio contextRef="c349" unitRef="u4" decimals="INF">4490</h:ValueOfKeyFigureOrFinancialRatio>
  <h:ValueOfKeyFigureOrFinancialRatio contextRef="c350" unitRef="u4" decimals="INF">1575</h:ValueOfKeyFigureOrFinancialRatio>
  <h:ValueOfKeyFigureOrFinancialRatio contextRef="c351" unitRef="u4" decimals="INF">198</h:ValueOfKeyFigureOrFinancialRatio>
  <h:ValueOfKeyFigureOrFinancialRatio contextRef="c352" unitRef="u4" decimals="INF">4942</h:ValueOfKeyFigureOrFinancialRatio>
  <h:ValueOfKeyFigureOrFinancialRatio contextRef="c353" unitRef="u4" decimals="INF">4145</h:ValueOfKeyFigureOrFinancialRatio>
  <e:Assets contextRef="c14" unitRef="u2" decimals="-3">56340000</e:Assets>
  <e:Assets contextRef="c17" unitRef="u2" decimals="-3">31608000</e:Assets>
  <e:Assets contextRef="c20" unitRef="u2" decimals="-3">21710000</e:Assets>
  <e:InvestmentInPropertyPlantAndEquipment contextRef="c1" unitRef="u2" decimals="-3">936000</e:InvestmentInPropertyPlantAndEquipment>
  <e:InvestmentInPropertyPlantAndEquipment contextRef="c10" unitRef="u2" decimals="-3">3270000</e:InvestmentInPropertyPlantAndEquipment>
  <e:InvestmentInPropertyPlantAndEquipment contextRef="c12" unitRef="u2" decimals="-3">18540000</e:InvestmentInPropertyPlantAndEquipment>
  <e:InvestmentInPropertyPlantAndEquipment contextRef="c15" unitRef="u2" decimals="-3">8395000</e:InvestmentInPropertyPlantAndEquipment>
  <e:InvestmentInPropertyPlantAndEquipment contextRef="c18" unitRef="u2" decimals="-3">21000</e:InvestmentInPropertyPlantAndEquipment>
  <e:Equity contextRef="c14" unitRef="u2" decimals="-3">52571000</e:Equity>
  <e:Equity contextRef="c17" unitRef="u2" decimals="-3">13474000</e:Equity>
  <e:Equity contextRef="c20" unitRef="u2" decimals="-3">20472000</e:Equity>
  <e:CashFlowsFromUsedInOperatingActivities contextRef="c12" unitRef="u2" decimals="-3">-12702000</e:CashFlowsFromUsedInOperatingActivities>
  <e:CashFlowsFromUsedInOperatingActivities contextRef="c15" unitRef="u2" decimals="-3">-2545000</e:CashFlowsFromUsedInOperatingActivities>
  <e:CashFlowsFromUsedInOperatingActivities contextRef="c18" unitRef="u2" decimals="-3">-5575000</e:CashFlowsFromUsedInOperatingActivities>
  <e:CashFlowsFromUsedInInvestingActivities contextRef="c12" unitRef="u2" decimals="-3">-18545000</e:CashFlowsFromUsedInInvestingActivities>
  <e:CashFlowsFromUsedInInvestingActivities contextRef="c15" unitRef="u2" decimals="-3">-8877000</e:CashFlowsFromUsedInInvestingActivities>
  <e:CashFlowsFromUsedInInvestingActivities contextRef="c18" unitRef="u2" decimals="-3">-27000</e:CashFlowsFromUsedInInvestingActivities>
  <e:CashFlowsFromUsedInFinancingActivities contextRef="c12" unitRef="u2" decimals="-3">35882000</e:CashFlowsFromUsedInFinancingActivities>
  <e:CashFlowsFromUsedInFinancingActivities contextRef="c15" unitRef="u2" decimals="-3">15000000</e:CashFlowsFromUsedInFinancingActivities>
  <e:CashFlowsFromUsedInFinancingActivities contextRef="c18" unitRef="u2" decimals="-3">23749000</e:CashFlowsFromUsedInFinancingActivities>
  <h:NameOfKeyFigureOrFinancialRatio contextRef="c374">EBITDA</h:NameOfKeyFigureOrFinancialRatio>
  <h:ValueOfKeyFigureOrFinancialRatio contextRef="c374" unitRef="u4" decimals="2">-13215</h:ValueOfKeyFigureOrFinancialRatio>
  <h:ValueOfKeyFigureOrFinancialRatio contextRef="c375" unitRef="u4" decimals="2">-12991</h:ValueOfKeyFigureOrFinancialRatio>
  <h:ValueOfKeyFigureOrFinancialRatio contextRef="c376" unitRef="u4" decimals="2">-11831</h:ValueOfKeyFigureOrFinancialRatio>
  <h:ValueOfKeyFigureOrFinancialRatio contextRef="c377" unitRef="u4" decimals="2">4417</h:ValueOfKeyFigureOrFinancialRatio>
  <h:ValueOfKeyFigureOrFinancialRatio contextRef="c378" unitRef="u4" decimals="2">3591</h:ValueOfKeyFigureOrFinancialRatio>
  <h:NameOfKeyFigureOrFinancialRatio contextRef="c409">Result per share</h:NameOfKeyFigureOrFinancialRatio>
  <h:ValueOfKeyFigureOrFinancialRatio contextRef="c409" unitRef="u4" decimals="2">-1</h:ValueOfKeyFigureOrFinancialRatio>
  <h:ValueOfKeyFigureOrFinancialRatio contextRef="c410" unitRef="u4" decimals="2">-1</h:ValueOfKeyFigureOrFinancialRatio>
  <h:ValueOfKeyFigureOrFinancialRatio contextRef="c411" unitRef="u4" decimals="2">-1</h:ValueOfKeyFigureOrFinancialRatio>
  <h:ValueOfKeyFigureOrFinancialRatio contextRef="c412" unitRef="u4" decimals="2">0</h:ValueOfKeyFigureOrFinancialRatio>
  <h:ValueOfKeyFigureOrFinancialRatio contextRef="c413" unitRef="u4" decimals="2">0</h:ValueOfKeyFigureOrFinancialRatio>
  <h:NameOfKeyFigureOrFinancialRatio contextRef="c384">Solidity (%)</h:NameOfKeyFigureOrFinancialRatio>
  <h:ValueOfKeyFigureOrFinancialRatio contextRef="c384" unitRef="u4" decimals="2">61</h:ValueOfKeyFigureOrFinancialRatio>
  <h:ValueOfKeyFigureOrFinancialRatio contextRef="c385" unitRef="u4" decimals="2">92</h:ValueOfKeyFigureOrFinancialRatio>
  <h:ValueOfKeyFigureOrFinancialRatio contextRef="c386" unitRef="u4" decimals="2">93</h:ValueOfKeyFigureOrFinancialRatio>
  <h:ValueOfKeyFigureOrFinancialRatio contextRef="c387" unitRef="u4" decimals="2">43</h:ValueOfKeyFigureOrFinancialRatio>
  <h:ValueOfKeyFigureOrFinancialRatio contextRef="c388" unitRef="u4" decimals="2">94</h:ValueOfKeyFigureOrFinancialRatio>
  <h:DescriptionOfPrimaryActivitiesOfEntity contextRef="c1" xml:lang="en">Primary activities
STENOCARE A/S was founded in 2017 with the purpose of supplying medical cannabis to patients in Denmark and internationally with the vision of creating a better quality of life for patients through the use of medical cannabis as an alternative and/or a supplement to traditional medicine. The Company was first to receive the Danish Medicines Agency's permission to import, distribute as well as cultivate and produce medical cannabis. The Company is a supplier of medical cannabis oil for patients in Denmark, Sweden, UK, Australia and Norway. Stenocare has an indoor production facility for the cultivation and production of medical cannabis at the Company's premises in Randers, Denmark. Stenocare has one subsidiary, Stenocare Ireland Ltd. The Subsidiary has no financial activity, and no consolidated figures apply.

</h:DescriptionOfPrimaryActivitiesOfEntity>
  <h:DescriptionOfDevelopmentInActivitiesAndFinancialAffairs contextRef="c1" xml:lang="en">Development in activities and financial affairs
STENOCARE worked intensively in 2022 with the four strategic assets



In all four assets Stenocare have made progress although it was realised once again that regulatory processes takes time. 

In the first quarter a product (THC) was approved by the Danish Medicines Agency for sale to Danish patients. Stenocare was again the only supplier of medical cannabis oil product under the Danish Pilot Programme. Also in the first quarter Stenocare could announce positive feasibility study with development of a new medical cannabis oil formulation that has the potential to improve the uptake of cannabinoids to be consistent in patients. Stenocare also enters the UK market with three medical cannabis oil products.

In the second quarter the THC medical cannabis products became available for patients in Denmark.

In the third quarter Stenocare announced entry to its 4th market starting sales in Australia later in 2022. Subsequent to the positive feasibility study announced in the first quarter Stenocare announces ground-breaking results from the study of a new medical cannabis oil formulation. The study shows that the new formulation dramatically enhances the bioavailability and thus uptake of cannabinoids, regardless of meal consumption and inter-individual biological differences.

In the fourth quarter Stenocare announces that it has received approval from The Danish Medicines Agency to sell a new CBD medical cannabis oil product to Danish patients. With this, Stenocare once again becomes the only supplier of both CBD and THC medical cannabis oil products under the Danish Pilot Programme. Also Stenocare announced entering its 5th market Norway with 3 medical cannabis products. Stenocare has a distribution agreement with the leading distributor and pharmacy chain in Norway, Apotek1, to secure nationwide distribution from day one. To secure the funding of Stenocare an extraordinary general meeting authorized the board of directors to enter into convertible loan agreements of up to 11 mDKK. Stenocare has subsequently entered into such loan agreements of 3.9 mDKK with repayment in January 2024.

During the financial year Stenocare worked intensively with medicine agencies in several countries including Denmark to have products approved for sales to patients. The result of this worked is that Stenocare now have 11 products approved for sale in 5 countries - Denmark, Sweden, UK, Norway and Australia.

For the year an operating loss of DKK -16,527,682 includes cost related to increased activity in commercial, regulatory and supply chain activities. The number of employees is unchanged 9 as the company has been cautious in controlling cost due to later approved products and hence lower sales than expected. Depreciations are increased from DKK 1,087,403 to 3,312,651 as the production facility is operational the full year compared to last year.

Stenocare realised an EBITDA for the financial year of DKK -13,215,031 and a net profit at DKK -16,303,170. The result is a loss larger than expectations due to products approved later in the calendar year and hence lower sales than expected. The balance sheet shows an equity of DKK 24,142,742 and total assets of DKK 39,604,370.


Significant uncertainty as regards going concern
Stenocare expects to reach a break-even quarterly result by end 2023 through increased sales due to recent product approvals in Denmark, UK, Norway and Australia. Up to 5 mDKK is required to finance operational costs and working capital in 2023. Stenocare can adjust planned operational costs and investments in order to finance the company’s operations with available funds. 

Stenocare has debt of 11 mDKK including loans of 4,8 mDKK with maturity by 31 March 2023 and convertible loans of 3,5 mDKK with maturity 1 January 2024. After year end the loan of 4,8 mDKK is prolonged to fall due on 30 June 2023. Management has together with an external advisor initiated plans to secure funding of 15-17 mDKK in 2023 to service the loans and planned operational cost. 
 
The Financial Statements are prepared after the assumptions, that the funding and refinancing will be solved, and therefore prepared on a going concern basis. Also, the company has on several occasions raised funding as equity as well as loans. However, material uncertainty exists to the company’s continued operations if for some reason the funding is not secured. The auditors refer to this situation in their report on the 2022 financial statements, though it is noted that their opinion is not modified in respect of this matter.

</h:DescriptionOfDevelopmentInActivitiesAndFinancialAffairs>
  <h:DescriptionOfExpectedDevelopment contextRef="c1" xml:lang="en">Outlook
Products approved in Denmark, Sweden, UK, Norway and Australia, and the learnings from these approval processes adding even more markets during 2023 gives confidence in increased sales for 2023. Stenocare expects to file an application for one or two new medical cannabis products with the Danish Medicine Agency in 2023.

Stenocare also expects to file an application with the Danish Medicine Agency for producing and selling medical cannabis bulk products from the production facility during 2023. The timing of the approval depends on the process time at the Danish Medicine Agency.

Therefore, expectations to EBITDA in 2023 is a loss lower than realised in 2022. The Company expects the sales to reach a level of 15-20 mDKK in 2023.

Stenocare has loans of 4,8 mDKK with maturity by 31 March 2023. After year-end this is prolonged to 30 June 2023. Management is planning to convert and/or refinance these loans in 2023 with equity or additional loan agreements under the convertible loan authorisation of 11 mDKK.

</h:DescriptionOfExpectedDevelopment>
  <h:DescriptionOfKnowledgeResources contextRef="c1" xml:lang="en">Knowledge resources
STENOCARE's operations are managed by highly trained and experienced employees in various areas and knowledge, covering managing of start-up companies, local and international sales and production in the bio-tech and horticultural industry.  

</h:DescriptionOfKnowledgeResources>
  <h:DescriptionOfTheEntitysUseOfFinancialInstruments contextRef="c1" xml:lang="en">Financial risks
STENOCARE is operating under a four-year pilot-programme, enabling all Danish physicians to prescribe cannabis for medical use. The programme was initialised January 1st, 2018 and was in December 2021 extended with additional four years to December 31st, 2025. Stenocare mitigates the risk of the program not being extended or made permanent by increasing the number of markets to 10 countries in 2025. Also, in December 2021 the parliament confirmed the permanent legalization of Danish cultivation and production of medical cannabis. 

There is a risk allocated to the suppliers of the Company regarding their ability for continuation of product supply to Stenocare. The Company has established procedures to minimize these risks. In addition to ordinary risks related to the industry e.g., regulatory changes in which the Company is operating, the Company is exposed to currencies as finished products from suppliers are purchased in CAD and AUD, and then sold in DKK, SEK, NOK, GBP and AUD. 

</h:DescriptionOfTheEntitysUseOfFinancialInstruments>
  <h:DescriptionOfImpactOnExternalEnvironmentAndMeasuresOfPreventingReducingOrMitigatingDamage contextRef="c1" xml:lang="en">External environment
In 2022, Stenocare's operations included distribution of medical cannabis products from its suppliers. The Company is engaged in cultivation of Cannabis plants in the facility in Randers and has established procedures on limiting the impact of the environment from the cultivation. 

</h:DescriptionOfImpactOnExternalEnvironmentAndMeasuresOfPreventingReducingOrMitigatingDamage>
  <h:DescriptionOfResearchAndDevelopmentActivitiesInAndForReportingEntity contextRef="c1" xml:lang="en">Research and development activities
In 2022 Stenocare has been actively engaged in the qualification and development of protocols in relation to acceptance of new cannabis oil products. Also, the Company continued to research and develop the High-Tech Indoor Cultivation Facility aiming for a pharma-grade production facility and working with product approval processes in various countries. Based on the research and development activities with the Cultivation Facility Stenocare aims to begin cultivation and production of medical cannabis in the Company's premises in Randers and begin the approval process at the Danish Medicines Agency towards the end of 2023. In 2019 the Company signed a strategic partnership agreement to develop, test and commercialize advanced cannabis-based medical products with a Danish company. In 2022 the Company got positive results from a study of a new oil formulation for cannabis-based medical products showing that the new formulation dramatically enhances the bioavailability and thus uptake of cannabinoids, regardless of meal consumption and inter-individual biological differences.

</h:DescriptionOfResearchAndDevelopmentActivitiesInAndForReportingEntity>
  <h:DescriptionOfSignificantEventsOccurringAfterEndOfReportingPeriod contextRef="c1" xml:lang="en">Subsequent events
After the end of the financial year, the maturity of loans of 4.8 mDKK has been postponed from 31 March 2023 to 30 June 2023. Other than this no important events have occurred after the end of the financial year which have a significant impact on the financial statements. 

</h:DescriptionOfSignificantEventsOccurringAfterEndOfReportingPeriod>
  <e:DisclosureOfTreasuryShares contextRef="c1" xml:lang="en">Treasury shares
</e:DisclosureOfTreasuryShares>
  <e:InformationOnTreasurySharesHold contextRef="c1" xml:lang="en">Treasury shares consist of:




Holding of treasury shares as at 01.01.22
Additions during the year


Holding of treasury shares as at 31.12.22

</e:InformationOnTreasurySharesHold>
  <e:DescriptionOfTreasurySharesHold contextRef="c1445">Holding of treasury shares</e:DescriptionOfTreasurySharesHold>
  <e:NumberOfTreasurySharesHold contextRef="c1444" unitRef="u1" decimals="INF">265927</e:NumberOfTreasurySharesHold>
  <e:AccountingParValueOfTreasurySharesHold contextRef="c1445" unitRef="u2" decimals="0">21274</e:AccountingParValueOfTreasurySharesHold>
  <e:PercentageOfContributedCapitalOfTreasurySharesHold contextRef="c1444" unitRef="u4" decimals="1">2</e:PercentageOfContributedCapitalOfTreasurySharesHold>
  <e:DescriptionOfTreasurySharesAcquired contextRef="c1446">Additions during the year</e:DescriptionOfTreasurySharesAcquired>
  <e:PurchasePriceOfTreasurySharesAcquiredAsSecurity contextRef="c1448" unitRef="u2" decimals="0">-354728</e:PurchasePriceOfTreasurySharesAcquiredAsSecurity>
  <e:NumberOfTreasurySharesAcquired contextRef="c1446" unitRef="u1" decimals="INF">-11120</e:NumberOfTreasurySharesAcquired>
  <e:AccountingParValueOfTreasurySharesAcquired contextRef="c1446" unitRef="u2" decimals="0">-890</e:AccountingParValueOfTreasurySharesAcquired>
  <e:PercentageOfContributedCapitalOfTreasurySharesAcquired contextRef="c1446" unitRef="u4" decimals="1">0</e:PercentageOfContributedCapitalOfTreasurySharesAcquired>
  <e:ExplanationOfReasonForAcquisitionOfTreasuryShares contextRef="c1446" xml:lang="en" />
  <e:GrossProfitLoss contextRef="c1" unitRef="u2" decimals="0">-6409657</e:GrossProfitLoss>
  <e:GrossProfitLoss contextRef="c10" unitRef="u2" decimals="-3">-5758000</e:GrossProfitLoss>
  <e:EmployeeBenefitsExpense contextRef="c1" unitRef="u2" decimals="0">6805374</e:EmployeeBenefitsExpense>
  <e:EmployeeBenefitsExpense contextRef="c10" unitRef="u2" decimals="-3">7234000</e:EmployeeBenefitsExpense>
  <e:DepreciationAmortisationExpenseAndImpairmentLossesOfPropertyPlantAndEquipmentAndIntangibleAssetsRecognisedInProfitOrLoss contextRef="c1" unitRef="u2" decimals="0">3312651</e:DepreciationAmortisationExpenseAndImpairmentLossesOfPropertyPlantAndEquipmentAndIntangibleAssetsRecognisedInProfitOrLoss>
  <e:DepreciationAmortisationExpenseAndImpairmentLossesOfPropertyPlantAndEquipmentAndIntangibleAssetsRecognisedInProfitOrLoss contextRef="c10" unitRef="u2" decimals="-3">1087000</e:DepreciationAmortisationExpenseAndImpairmentLossesOfPropertyPlantAndEquipmentAndIntangibleAssetsRecognisedInProfitOrLoss>
  <e:ProfitLossFromOrdinaryOperatingActivities contextRef="c1" unitRef="u2" decimals="0">-16527682</e:ProfitLossFromOrdinaryOperatingActivities>
  <e:ProfitLossFromOrdinaryOperatingActivities contextRef="c10" unitRef="u2" decimals="-3">-14079000</e:ProfitLossFromOrdinaryOperatingActivities>
  <e:IncomeFromInvestmentsInGroupEnterprises contextRef="c1" unitRef="u2" decimals="0">-82262</e:IncomeFromInvestmentsInGroupEnterprises>
  <e:IncomeFromInvestmentsInGroupEnterprises contextRef="c10" unitRef="u2" decimals="-3">0</e:IncomeFromInvestmentsInGroupEnterprises>
  <e:OtherFinanceIncome contextRef="c1" unitRef="u2" decimals="0">16989</e:OtherFinanceIncome>
  <e:OtherFinanceIncome contextRef="c10" unitRef="u2" decimals="-3">32000</e:OtherFinanceIncome>
  <e:OtherFinanceExpenses contextRef="c1" unitRef="u2" decimals="0">1294561</e:OtherFinanceExpenses>
  <e:OtherFinanceExpenses contextRef="c10" unitRef="u2" decimals="-3">213000</e:OtherFinanceExpenses>
  <e:ProfitLossFromOrdinaryActivitiesBeforeTax contextRef="c1" unitRef="u2" decimals="0">-17887516</e:ProfitLossFromOrdinaryActivitiesBeforeTax>
  <e:ProfitLossFromOrdinaryActivitiesBeforeTax contextRef="c10" unitRef="u2" decimals="-3">-14260000</e:ProfitLossFromOrdinaryActivitiesBeforeTax>
  <e:TaxExpense contextRef="c1" unitRef="u2" decimals="0">-1584346</e:TaxExpense>
  <e:TaxExpense contextRef="c10" unitRef="u2" decimals="-3">-1528000</e:TaxExpense>
  <e:ProfitLoss contextRef="c1" unitRef="u2" decimals="0">-16303170</e:ProfitLoss>
  <e:ProfitLoss contextRef="c10" unitRef="u2" decimals="-3">-12732000</e:ProfitLoss>
  <e:LeaseholdImprovements contextRef="c45" unitRef="u2" decimals="0">1393710</e:LeaseholdImprovements>
  <e:LeaseholdImprovements contextRef="c44" unitRef="u2" decimals="-3">1005000</e:LeaseholdImprovements>
  <e:PlantAndMachinery contextRef="c45" unitRef="u2" decimals="0">24024844</e:PlantAndMachinery>
  <e:PlantAndMachinery contextRef="c44" unitRef="u2" decimals="-3">26836000</e:PlantAndMachinery>
  <e:FixturesFittingsToolsAndEquipment contextRef="c45" unitRef="u2" decimals="0">561766</e:FixturesFittingsToolsAndEquipment>
  <e:FixturesFittingsToolsAndEquipment contextRef="c44" unitRef="u2" decimals="-3">516000</e:FixturesFittingsToolsAndEquipment>
  <e:PropertyPlantAndEquipment contextRef="c45" unitRef="u2" decimals="0">25980320</e:PropertyPlantAndEquipment>
  <e:PropertyPlantAndEquipment contextRef="c44" unitRef="u2" decimals="-3">28357000</e:PropertyPlantAndEquipment>
  <e:LongtermInvestmentsInGroupEnterprises contextRef="c45" unitRef="u2" decimals="0">0</e:LongtermInvestmentsInGroupEnterprises>
  <e:LongtermInvestmentsInGroupEnterprises contextRef="c44" unitRef="u2" decimals="-3">0</e:LongtermInvestmentsInGroupEnterprises>
  <e:DepositsLongtermInvestmentsAndReceivables contextRef="c45" unitRef="u2" decimals="0">494104</e:DepositsLongtermInvestmentsAndReceivables>
  <e:DepositsLongtermInvestmentsAndReceivables contextRef="c44" unitRef="u2" decimals="-3">493000</e:DepositsLongtermInvestmentsAndReceivables>
  <e:LongtermInvestmentsAndReceivables contextRef="c45" unitRef="u2" decimals="0">494104</e:LongtermInvestmentsAndReceivables>
  <e:LongtermInvestmentsAndReceivables contextRef="c44" unitRef="u2" decimals="-3">493000</e:LongtermInvestmentsAndReceivables>
  <e:NoncurrentAssets contextRef="c45" unitRef="u2" decimals="0">26474424</e:NoncurrentAssets>
  <e:NoncurrentAssets contextRef="c44" unitRef="u2" decimals="-3">28850000</e:NoncurrentAssets>
  <e:ManufacturedGoodsAndGoodsForResale contextRef="c45" unitRef="u2" decimals="0">727909</e:ManufacturedGoodsAndGoodsForResale>
  <e:ManufacturedGoodsAndGoodsForResale contextRef="c44" unitRef="u2" decimals="-3">0</e:ManufacturedGoodsAndGoodsForResale>
  <e:Inventories contextRef="c45" unitRef="u2" decimals="0">727909</e:Inventories>
  <e:Inventories contextRef="c44" unitRef="u2" decimals="-3">0</e:Inventories>
  <e:ShorttermTradeReceivables contextRef="c45" unitRef="u2" decimals="0">3624656</e:ShorttermTradeReceivables>
  <e:ShorttermTradeReceivables contextRef="c44" unitRef="u2" decimals="-3">0</e:ShorttermTradeReceivables>
  <e:ShorttermReceivablesFromGroupEnterprises contextRef="c45" unitRef="u2" decimals="0">0</e:ShorttermReceivablesFromGroupEnterprises>
  <e:ShorttermReceivablesFromGroupEnterprises contextRef="c44" unitRef="u2" decimals="-3">18000</e:ShorttermReceivablesFromGroupEnterprises>
  <e:CurrentDeferredTaxAssets contextRef="c45" unitRef="u2" decimals="0">1357120</e:CurrentDeferredTaxAssets>
  <e:CurrentDeferredTaxAssets contextRef="c44" unitRef="u2" decimals="-3">1377000</e:CurrentDeferredTaxAssets>
  <e:ShorttermTaxReceivables contextRef="c45" unitRef="u2" decimals="0">1604580</e:ShorttermTaxReceivables>
  <e:ShorttermTaxReceivables contextRef="c44" unitRef="u2" decimals="-3">1363000</e:ShorttermTaxReceivables>
  <e:OtherShorttermReceivables contextRef="c45" unitRef="u2" decimals="0">1077264</e:OtherShorttermReceivables>
  <e:OtherShorttermReceivables contextRef="c44" unitRef="u2" decimals="-3">454000</e:OtherShorttermReceivables>
  <e:DeferredIncomeAssets contextRef="c45" unitRef="u2" decimals="0">309028</e:DeferredIncomeAssets>
  <e:DeferredIncomeAssets contextRef="c44" unitRef="u2" decimals="-3">153000</e:DeferredIncomeAssets>
  <e:ShorttermReceivables contextRef="c45" unitRef="u2" decimals="0">7972648</e:ShorttermReceivables>
  <e:ShorttermReceivables contextRef="c44" unitRef="u2" decimals="-3">3365000</e:ShorttermReceivables>
  <e:CashAndCashEquivalents contextRef="c45" unitRef="u2" decimals="0">4429389</e:CashAndCashEquivalents>
  <e:CashAndCashEquivalents contextRef="c44" unitRef="u2" decimals="-3">11720000</e:CashAndCashEquivalents>
  <e:CurrentAssets contextRef="c45" unitRef="u2" decimals="0">13129946</e:CurrentAssets>
  <e:CurrentAssets contextRef="c44" unitRef="u2" decimals="-3">15085000</e:CurrentAssets>
  <e:Assets contextRef="c45" unitRef="u2" decimals="0">39604370</e:Assets>
  <e:Assets contextRef="c44" unitRef="u2" decimals="-3">43935000</e:Assets>
  <e:ContributedCapital contextRef="c45" unitRef="u2" decimals="0">934090</e:ContributedCapital>
  <e:ContributedCapital contextRef="c44" unitRef="u2" decimals="-3">934000</e:ContributedCapital>
  <e:RetainedEarnings contextRef="c45" unitRef="u2" decimals="0">23208652</e:RetainedEarnings>
  <e:RetainedEarnings contextRef="c44" unitRef="u2" decimals="-3">39308000</e:RetainedEarnings>
  <e:Equity contextRef="c45" unitRef="u2" decimals="0">24142742</e:Equity>
  <e:Equity contextRef="c44" unitRef="u2" decimals="-3">40242000</e:Equity>
  <e:OtherProvisions contextRef="c45" unitRef="u2" decimals="0">1053000</e:OtherProvisions>
  <e:OtherProvisions contextRef="c44" unitRef="u2" decimals="-3">315000</e:OtherProvisions>
  <e:Provisions contextRef="c45" unitRef="u2" decimals="0">1053000</e:Provisions>
  <e:Provisions contextRef="c44" unitRef="u2" decimals="-3">315000</e:Provisions>
  <e:ConvertibleProfitYieldingOrDividendYieldingLongtermDebtInstruments contextRef="c45" unitRef="u2" decimals="0">3530607</e:ConvertibleProfitYieldingOrDividendYieldingLongtermDebtInstruments>
  <e:ConvertibleProfitYieldingOrDividendYieldingLongtermDebtInstruments contextRef="c44" unitRef="u2" decimals="-3">0</e:ConvertibleProfitYieldingOrDividendYieldingLongtermDebtInstruments>
  <e:LongtermLeaseCommitments contextRef="c45" unitRef="u2" decimals="0">1266290</e:LongtermLeaseCommitments>
  <e:LongtermLeaseCommitments contextRef="c44" unitRef="u2" decimals="-3">988000</e:LongtermLeaseCommitments>
  <e:LongtermLiabilitiesOtherThanProvisions contextRef="c45" unitRef="u2" decimals="0">4796897</e:LongtermLiabilitiesOtherThanProvisions>
  <e:LongtermLiabilitiesOtherThanProvisions contextRef="c44" unitRef="u2" decimals="-3">988000</e:LongtermLiabilitiesOtherThanProvisions>
  <e:ShorttermPartOfLongtermLiabilitiesOtherThanProvisions contextRef="c45" unitRef="u2" decimals="0">415494</e:ShorttermPartOfLongtermLiabilitiesOtherThanProvisions>
  <e:ShorttermPartOfLongtermLiabilitiesOtherThanProvisions contextRef="c44" unitRef="u2" decimals="-3">255000</e:ShorttermPartOfLongtermLiabilitiesOtherThanProvisions>
  <e:ShorttermTradePayables contextRef="c45" unitRef="u2" decimals="0">3010508</e:ShorttermTradePayables>
  <e:ShorttermTradePayables contextRef="c44" unitRef="u2" decimals="-3">1188000</e:ShorttermTradePayables>
  <e:OtherShorttermPayables contextRef="c45" unitRef="u2" decimals="0">6185729</e:OtherShorttermPayables>
  <e:OtherShorttermPayables contextRef="c44" unitRef="u2" decimals="-3">947000</e:OtherShorttermPayables>
  <e:ShorttermLiabilitiesOtherThanProvisions contextRef="c45" unitRef="u2" decimals="0">9611731</e:ShorttermLiabilitiesOtherThanProvisions>
  <e:ShorttermLiabilitiesOtherThanProvisions contextRef="c44" unitRef="u2" decimals="-3">2390000</e:ShorttermLiabilitiesOtherThanProvisions>
  <e:LiabilitiesOtherThanProvisions contextRef="c45" unitRef="u2" decimals="0">14408628</e:LiabilitiesOtherThanProvisions>
  <e:LiabilitiesOtherThanProvisions contextRef="c44" unitRef="u2" decimals="-3">3378000</e:LiabilitiesOtherThanProvisions>
  <e:LiabilitiesAndEquity contextRef="c45" unitRef="u2" decimals="0">39604370</e:LiabilitiesAndEquity>
  <e:LiabilitiesAndEquity contextRef="c44" unitRef="u2" decimals="-3">43935000</e:LiabilitiesAndEquity>
  <e:Equity contextRef="c471" unitRef="u2" decimals="0">934090</e:Equity>
  <e:Equity contextRef="c491" unitRef="u2" decimals="0">51636473</e:Equity>
  <e:ValueAdjustmentsOfEquity contextRef="c492" unitRef="u2" decimals="0">404471</e:ValueAdjustmentsOfEquity>
  <e:ProfitLoss contextRef="c492" unitRef="u2" decimals="0">-12732465</e:ProfitLoss>
  <e:Equity contextRef="c473" unitRef="u2" decimals="0">934090</e:Equity>
  <e:Equity contextRef="c493" unitRef="u2" decimals="0">39308479</e:Equity>
  <e:ValueAdjustmentsOfEquity contextRef="c101" unitRef="u2" decimals="0">203343</e:ValueAdjustmentsOfEquity>
  <e:ProfitLoss contextRef="c101" unitRef="u2" decimals="0">-16303170</e:ProfitLoss>
  <e:Equity contextRef="c84" unitRef="u2" decimals="0">934090</e:Equity>
  <e:Equity contextRef="c102" unitRef="u2" decimals="0">23208652</e:Equity>
  <e:Adjustments contextRef="c1" unitRef="u2" decimals="0">3291482</e:Adjustments>
  <e:Adjustments contextRef="c10" unitRef="u2" decimals="-3">-106000</e:Adjustments>
  <e:DecreaseIncreaseInInventories contextRef="c1" unitRef="u2" decimals="0">-727909</e:DecreaseIncreaseInInventories>
  <e:DecreaseIncreaseInInventories contextRef="c10" unitRef="u2" decimals="-3">0</e:DecreaseIncreaseInInventories>
  <e:DecreaseIncreaseInReceivables contextRef="c1" unitRef="u2" decimals="0">-4664861</e:DecreaseIncreaseInReceivables>
  <e:DecreaseIncreaseInReceivables contextRef="c10" unitRef="u2" decimals="-3">137000</e:DecreaseIncreaseInReceivables>
  <e:DecreaseIncreaseInTradePayables contextRef="c1" unitRef="u2" decimals="0">1822439</e:DecreaseIncreaseInTradePayables>
  <e:DecreaseIncreaseInTradePayables contextRef="c10" unitRef="u2" decimals="-3">-1377000</e:DecreaseIncreaseInTradePayables>
  <e:OtherAdjustmentsForDecreaseIncreaseInWorkingCapital contextRef="c1" unitRef="u2" decimals="0">-447789</e:OtherAdjustmentsForDecreaseIncreaseInWorkingCapital>
  <e:OtherAdjustmentsForDecreaseIncreaseInWorkingCapital contextRef="c10" unitRef="u2" decimals="-3">-257000</e:OtherAdjustmentsForDecreaseIncreaseInWorkingCapital>
  <e:OtherProvisionsCashFlow contextRef="c1" unitRef="u2" decimals="0">738000</e:OtherProvisionsCashFlow>
  <e:OtherProvisionsCashFlow contextRef="c10" unitRef="u2" decimals="-3">315000</e:OtherProvisionsCashFlow>
  <e:CashFlowFromOperatingActivitiesBeforeFinancialItems contextRef="c1" unitRef="u2" decimals="0">-16291808</e:CashFlowFromOperatingActivitiesBeforeFinancialItems>
  <e:CashFlowFromOperatingActivitiesBeforeFinancialItems contextRef="c10" unitRef="u2" decimals="-3">-14020000</e:CashFlowFromOperatingActivitiesBeforeFinancialItems>
  <e:InterestReceivedClassifiedAsOperatingActivities contextRef="c1" unitRef="u2" decimals="0">0</e:InterestReceivedClassifiedAsOperatingActivities>
  <e:InterestReceivedClassifiedAsOperatingActivities contextRef="c10" unitRef="u2" decimals="-3">32000</e:InterestReceivedClassifiedAsOperatingActivities>
  <e:InterestPaidClassifiedAsOperatingActivities contextRef="c1" unitRef="u2" decimals="0">-103417</e:InterestPaidClassifiedAsOperatingActivities>
  <e:InterestPaidClassifiedAsOperatingActivities contextRef="c10" unitRef="u2" decimals="-3">-213000</e:InterestPaidClassifiedAsOperatingActivities>
  <e:IncomeTaxesPaidRefundClassifiedAsOperatingActivities contextRef="c1" unitRef="u2" decimals="0">1362568</e:IncomeTaxesPaidRefundClassifiedAsOperatingActivities>
  <e:IncomeTaxesPaidRefundClassifiedAsOperatingActivities contextRef="c10" unitRef="u2" decimals="-3">857000</e:IncomeTaxesPaidRefundClassifiedAsOperatingActivities>
  <e:CashFlowFromOrdinaryOperatingActivities contextRef="c1" unitRef="u2" decimals="0">-15032657</e:CashFlowFromOrdinaryOperatingActivities>
  <e:CashFlowFromOrdinaryOperatingActivities contextRef="c10" unitRef="u2" decimals="-3">-13344000</e:CashFlowFromOrdinaryOperatingActivities>
  <e:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities contextRef="c1" unitRef="u2" decimals="0">-935866</e:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
  <e:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities contextRef="c10" unitRef="u2" decimals="-3">-3270000</e:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
  <e:ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities contextRef="c1" unitRef="u2" decimals="0">0</e:ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
  <e:ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities contextRef="c10" unitRef="u2" decimals="-3">731000</e:ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
  <e:Loans contextRef="c1" unitRef="u2" decimals="0">-975</e:Loans>
  <e:Loans contextRef="c10" unitRef="u2" decimals="-3">0</e:Loans>
  <e:CashFlowsFromUsedInInvestingActivities contextRef="c1" unitRef="u2" decimals="0">-936841</e:CashFlowsFromUsedInInvestingActivities>
  <e:CashFlowsFromUsedInInvestingActivities contextRef="c10" unitRef="u2" decimals="-3">-2539000</e:CashFlowsFromUsedInInvestingActivities>
  <e:RaisingOfDebtToCreditInstitutions contextRef="c1" unitRef="u2" decimals="0">8239787</e:RaisingOfDebtToCreditInstitutions>
  <e:RaisingOfDebtToCreditInstitutions contextRef="c10" unitRef="u2" decimals="-3">0</e:RaisingOfDebtToCreditInstitutions>
  <e:RepaymentOfDebtToCreditInstitutions contextRef="c1" unitRef="u2" decimals="0">859243</e:RepaymentOfDebtToCreditInstitutions>
  <e:RepaymentOfDebtToCreditInstitutions contextRef="c10" unitRef="u2" decimals="-3">1371000</e:RepaymentOfDebtToCreditInstitutions>
  <e:ReductionOfLeaseCommitments contextRef="c1" unitRef="u2" decimals="0">-420165</e:ReductionOfLeaseCommitments>
  <e:ReductionOfLeaseCommitments contextRef="c10" unitRef="u2" decimals="-3">-128000</e:ReductionOfLeaseCommitments>
  <e:CashFlowsFromUsedInFinancingActivities contextRef="c1" unitRef="u2" decimals="0">8678865</e:CashFlowsFromUsedInFinancingActivities>
  <e:CashFlowsFromUsedInFinancingActivities contextRef="c10" unitRef="u2" decimals="-3">1243000</e:CashFlowsFromUsedInFinancingActivities>
  <e:NetIncreaseDecreaseInCashAndCashEquivalents contextRef="c1" unitRef="u2" decimals="0">-7290633</e:NetIncreaseDecreaseInCashAndCashEquivalents>
  <e:NetIncreaseDecreaseInCashAndCashEquivalents contextRef="c10" unitRef="u2" decimals="-3">-14640000</e:NetIncreaseDecreaseInCashAndCashEquivalents>
  <e:CashAndCashEquivalents contextRef="c256" unitRef="u2" decimals="0">11720022</e:CashAndCashEquivalents>
  <e:CashAndCashEquivalents contextRef="c257" unitRef="u2" decimals="-3">26360000</e:CashAndCashEquivalents>
  <e:CashAndCashEquivalentsConcerningCashflowStatement contextRef="c45" unitRef="u2" decimals="0">4429389</e:CashAndCashEquivalentsConcerningCashflowStatement>
  <e:CashAndCashEquivalentsConcerningCashflowStatement contextRef="c44" unitRef="u2" decimals="-3">11720000</e:CashAndCashEquivalentsConcerningCashflowStatement>
  <e:CashAndCashEquivalents contextRef="c45" unitRef="u2" decimals="0">4429389</e:CashAndCashEquivalents>
  <e:CashAndCashEquivalents contextRef="c44" unitRef="u2" decimals="-3">11720000</e:CashAndCashEquivalents>
  <e:WagesAndSalaries contextRef="c1" unitRef="u2" decimals="0">6422414</e:WagesAndSalaries>
  <e:WagesAndSalaries contextRef="c10" unitRef="u2" decimals="-3">6836000</e:WagesAndSalaries>
  <e:PostemploymentBenefitExpense contextRef="c1" unitRef="u2" decimals="0">144556</e:PostemploymentBenefitExpense>
  <e:PostemploymentBenefitExpense contextRef="c10" unitRef="u2" decimals="-3">180000</e:PostemploymentBenefitExpense>
  <e:SocialSecurityContributions contextRef="c1" unitRef="u2" decimals="0">21080</e:SocialSecurityContributions>
  <e:SocialSecurityContributions contextRef="c10" unitRef="u2" decimals="-3">20000</e:SocialSecurityContributions>
  <e:OtherEmployeeExpense contextRef="c1" unitRef="u2" decimals="0">217324</e:OtherEmployeeExpense>
  <e:OtherEmployeeExpense contextRef="c10" unitRef="u2" decimals="-3">198000</e:OtherEmployeeExpense>
  <e:AverageNumberOfEmployees contextRef="c1" unitRef="u4" decimals="INF">9</e:AverageNumberOfEmployees>
  <e:AverageNumberOfEmployees contextRef="c10" unitRef="u4" decimals="INF">9</e:AverageNumberOfEmployees>
  <e:RemunerationOfManagementCategory contextRef="c121" unitRef="u2" decimals="0">804000</e:RemunerationOfManagementCategory>
  <e:RemunerationOfManagementCategory contextRef="c122" unitRef="u2" decimals="0">804</e:RemunerationOfManagementCategory>
  <e:RemunerationOfManagementCategories contextRef="c1" unitRef="u2" decimals="0">1154000</e:RemunerationOfManagementCategories>
  <e:RemunerationOfManagementCategories contextRef="c10" unitRef="u2" decimals="-3">1154000</e:RemunerationOfManagementCategories>
  <e:CurrentTaxExpense contextRef="c1" unitRef="u2" decimals="0">-1604624</e:CurrentTaxExpense>
  <e:CurrentTaxExpense contextRef="c10" unitRef="u2" decimals="-3">-1363000</e:CurrentTaxExpense>
  <e:AdjustmentsForDeferredTax contextRef="c1" unitRef="u2" decimals="0">20278</e:AdjustmentsForDeferredTax>
  <e:AdjustmentsForDeferredTax contextRef="c10" unitRef="u2" decimals="-3">-165000</e:AdjustmentsForDeferredTax>
  <e:ProfitLoss contextRef="c40" unitRef="u2" decimals="0">-16303170</e:ProfitLoss>
  <e:ProfitLoss contextRef="c41" unitRef="u2" decimals="-3">-12732000</e:ProfitLoss>
  <e:PropertyPlantAndEquipmentGross contextRef="c182" unitRef="u2" decimals="0">1119359</e:PropertyPlantAndEquipmentGross>
  <e:PropertyPlantAndEquipmentGross contextRef="c176" unitRef="u2" decimals="0">27688322</e:PropertyPlantAndEquipmentGross>
  <e:PropertyPlantAndEquipmentGross contextRef="c179" unitRef="u2" decimals="0">686488</e:PropertyPlantAndEquipmentGross>
  <e:AdditionsToPropertyPlantAndEquipment contextRef="c183" unitRef="u2" decimals="0">707035</e:AdditionsToPropertyPlantAndEquipment>
  <e:AdditionsToPropertyPlantAndEquipment contextRef="c180" unitRef="u2" decimals="0">228831</e:AdditionsToPropertyPlantAndEquipment>
  <e:PropertyPlantAndEquipmentGross contextRef="c184" unitRef="u2" decimals="0">1826394</e:PropertyPlantAndEquipmentGross>
  <e:PropertyPlantAndEquipmentGross contextRef="c178" unitRef="u2" decimals="0">27688322</e:PropertyPlantAndEquipmentGross>
  <e:PropertyPlantAndEquipmentGross contextRef="c181" unitRef="u2" decimals="0">915319</e:PropertyPlantAndEquipmentGross>
  <e:AccumulatedImpairmentLossesAndDepreciationOfPropertyPlantAndEquipment contextRef="c182" unitRef="u2" decimals="0">-114556</e:AccumulatedImpairmentLossesAndDepreciationOfPropertyPlantAndEquipment>
  <e:AccumulatedImpairmentLossesAndDepreciationOfPropertyPlantAndEquipment contextRef="c176" unitRef="u2" decimals="0">-852022</e:AccumulatedImpairmentLossesAndDepreciationOfPropertyPlantAndEquipment>
  <e:AccumulatedImpairmentLossesAndDepreciationOfPropertyPlantAndEquipment contextRef="c179" unitRef="u2" decimals="0">-170486</e:AccumulatedImpairmentLossesAndDepreciationOfPropertyPlantAndEquipment>
  <e:DepreciationOfPropertyPlantAndEquipment contextRef="c183" unitRef="u2" decimals="0">-318128</e:DepreciationOfPropertyPlantAndEquipment>
  <e:DepreciationOfPropertyPlantAndEquipment contextRef="c177" unitRef="u2" decimals="0">-2811456</e:DepreciationOfPropertyPlantAndEquipment>
  <e:DepreciationOfPropertyPlantAndEquipment contextRef="c180" unitRef="u2" decimals="0">-183067</e:DepreciationOfPropertyPlantAndEquipment>
  <e:AccumulatedImpairmentLossesAndDepreciationOfPropertyPlantAndEquipment contextRef="c184" unitRef="u2" decimals="0">-432684</e:AccumulatedImpairmentLossesAndDepreciationOfPropertyPlantAndEquipment>
  <e:AccumulatedImpairmentLossesAndDepreciationOfPropertyPlantAndEquipment contextRef="c178" unitRef="u2" decimals="0">-3663478</e:AccumulatedImpairmentLossesAndDepreciationOfPropertyPlantAndEquipment>
  <e:AccumulatedImpairmentLossesAndDepreciationOfPropertyPlantAndEquipment contextRef="c181" unitRef="u2" decimals="0">-353553</e:AccumulatedImpairmentLossesAndDepreciationOfPropertyPlantAndEquipment>
  <e:PropertyPlantAndEquipment contextRef="c184" unitRef="u2" decimals="0">1393710</e:PropertyPlantAndEquipment>
  <e:PropertyPlantAndEquipment contextRef="c178" unitRef="u2" decimals="0">24024844</e:PropertyPlantAndEquipment>
  <e:PropertyPlantAndEquipment contextRef="c181" unitRef="u2" decimals="0">561766</e:PropertyPlantAndEquipment>
  <e:PropertyPlantAndEquipment contextRef="c1004" unitRef="u2" decimals="0">1267960</e:PropertyPlantAndEquipment>
  <e:PropertyPlantAndEquipment contextRef="c1000" unitRef="u2" decimals="0">0</e:PropertyPlantAndEquipment>
  <e:PropertyPlantAndEquipment contextRef="c1001" unitRef="u2" decimals="0">427184</e:PropertyPlantAndEquipment>
  <e:InvestmentsGross contextRef="c46" unitRef="u2" decimals="0">7</e:InvestmentsGross>
  <e:InvestmentsGross contextRef="c50" unitRef="u2" decimals="0">7</e:InvestmentsGross>
  <e:AccumulatedImpairmentLossesAndDepreciationOfInvestments contextRef="c46" unitRef="u2" decimals="0">-7</e:AccumulatedImpairmentLossesAndDepreciationOfInvestments>
  <e:ProfitLossRelatedToInvestments contextRef="c48" unitRef="u2" decimals="0">-82262</e:ProfitLossRelatedToInvestments>
  <e:InvestmentsWithNegativeEquityDepreciatedOverReceivables contextRef="c48" unitRef="u2" decimals="0">82262</e:InvestmentsWithNegativeEquityDepreciatedOverReceivables>
  <e:AccumulatedImpairmentLossesAndDepreciationOfInvestments contextRef="c50" unitRef="u2" decimals="0">-7</e:AccumulatedImpairmentLossesAndDepreciationOfInvestments>
  <e:LongtermInvestmentsAndReceivables contextRef="c50" unitRef="u2" decimals="0">0</e:LongtermInvestmentsAndReceivables>
  <e:RelatedEntityName contextRef="c317">STENOCARE Ireland Ltd.</e:RelatedEntityName>
  <e:RelatedEntityRegisteredOffice contextRef="c317">Ireland</e:RelatedEntityRegisteredOffice>
  <e:ShareHeldByEntityOrConsolidatedEnterprisesInRelatedEntity contextRef="c318" unitRef="u4" decimals="1">100</e:ShareHeldByEntityOrConsolidatedEnterprisesInRelatedEntity>
  <e:InvestmentsGross contextRef="c1006" unitRef="u2" decimals="0">493129</e:InvestmentsGross>
  <e:AdditionsToInvestments contextRef="c1007" unitRef="u2" decimals="0">975</e:AdditionsToInvestments>
  <e:InvestmentsGross contextRef="c1008" unitRef="u2" decimals="0">494104</e:InvestmentsGross>
  <e:LongtermInvestmentsAndReceivables contextRef="c1008" unitRef="u2" decimals="0">494104</e:LongtermInvestmentsAndReceivables>
  <e:ProvisionsForDeferredTax contextRef="c256" unitRef="u2" decimals="0">1377398</e:ProvisionsForDeferredTax>
  <e:ProvisionsForDeferredTax contextRef="c257" unitRef="u2" decimals="-3">1213000</e:ProvisionsForDeferredTax>
  <e:DeferredTaxRecognisedInIncomeStatement contextRef="c45" unitRef="u2" decimals="0">-20278</e:DeferredTaxRecognisedInIncomeStatement>
  <e:DeferredTaxRecognisedInIncomeStatement contextRef="c44" unitRef="u2" decimals="-3">165000</e:DeferredTaxRecognisedInIncomeStatement>
  <e:DescriptionOfClassOfIssuedShares contextRef="c1444">Share capital</e:DescriptionOfClassOfIssuedShares>
  <e:NumberOfIssuedShares contextRef="c1444" unitRef="u1" decimals="INF">11676126</e:NumberOfIssuedShares>
  <e:NominalValueOfIssuedShares contextRef="c1444" unitRef="u2" decimals="0">934090</e:NominalValueOfIssuedShares>
  <e:LongtermLiabilitiesOtherThanProvisionsDueInOneYear contextRef="c216" unitRef="u2" decimals="0">0</e:LongtermLiabilitiesOtherThanProvisionsDueInOneYear>
  <e:LongtermLiabilitiesOtherThanProvisionsDueAfterFiveYearsAndMore contextRef="c216" unitRef="u2" decimals="0">0</e:LongtermLiabilitiesOtherThanProvisionsDueAfterFiveYearsAndMore>
  <e:LongtermLiabilitiesOtherThanProvisions contextRef="c216" unitRef="u2" decimals="0">3530607</e:LongtermLiabilitiesOtherThanProvisions>
  <e:LongtermLiabilitiesOtherThanProvisions contextRef="c217" unitRef="u2" decimals="-3">0</e:LongtermLiabilitiesOtherThanProvisions>
  <e:DepreciationAmortisationExpenseAndImpairmentLossesOfPropertyPlantAndEquipmentAndIntangibleAssets contextRef="c1" unitRef="u2" decimals="0">3312651</e:DepreciationAmortisationExpenseAndImpairmentLossesOfPropertyPlantAndEquipmentAndIntangibleAssets>
  <e:DepreciationAmortisationExpenseAndImpairmentLossesOfPropertyPlantAndEquipmentAndIntangibleAssets contextRef="c10" unitRef="u2" decimals="-3">1087000</e:DepreciationAmortisationExpenseAndImpairmentLossesOfPropertyPlantAndEquipmentAndIntangibleAssets>
  <e:AdjustmentsOfProfitFromGroupEnterprisesAfterTax contextRef="c1" unitRef="u2" decimals="0">82262</e:AdjustmentsOfProfitFromGroupEnterprisesAfterTax>
  <e:AdjustmentsOfProfitFromGroupEnterprisesAfterTax contextRef="c10" unitRef="u2" decimals="-3">0</e:AdjustmentsOfProfitFromGroupEnterprisesAfterTax>
  <e:AdjustmentsOfInterestAndSimilarIncomes contextRef="c1" unitRef="u2" decimals="0">-16989</e:AdjustmentsOfInterestAndSimilarIncomes>
  <e:AdjustmentsOfInterestAndSimilarIncomes contextRef="c10" unitRef="u2" decimals="-3">-32000</e:AdjustmentsOfInterestAndSimilarIncomes>
  <e:AdjustmentsfInterestAndSimilarExpenses contextRef="c1" unitRef="u2" decimals="0">1294561</e:AdjustmentsfInterestAndSimilarExpenses>
  <e:AdjustmentsfInterestAndSimilarExpenses contextRef="c10" unitRef="u2" decimals="-3">213000</e:AdjustmentsfInterestAndSimilarExpenses>
  <e:AdjustmentsOfTaxExpense contextRef="c1" unitRef="u2" decimals="0">-1584346</e:AdjustmentsOfTaxExpense>
  <e:AdjustmentsOfTaxExpense contextRef="c10" unitRef="u2" decimals="-3">-1527000</e:AdjustmentsOfTaxExpense>
  <e:OtherAdjustments contextRef="c1" unitRef="u2" decimals="0">203343</e:OtherAdjustments>
  <e:OtherAdjustments contextRef="c10" unitRef="u2" decimals="-3">404000</e:OtherAdjustments>
  <e:InformationOnReportingClassOfEntity contextRef="c1" xml:lang="en">The annual report is presented in accordance with the provisions of the Danish Financial Statements Act (Årsregnskabsloven) for medium-sized  enterprises in reporting class C.
</e:InformationOnReportingClassOfEntity>
  <e:InformationOnOmissionOfConsolidatedFinancialStatement contextRef="c1" xml:lang="en">In accordance with section 110 of the Danish Financial Statements Act, the company has not prepared consolidated financial statements.
</e:InformationOnOmissionOfConsolidatedFinancialStatement>
  <e:DescriptionOfGeneralMattersRelatedToRecognitionMeasurementAndChangesInAccountingPolicies contextRef="c1" xml:lang="en">Income is recognised in the income statement as earned, including value adjustments of financial assets and liabilities. All expenses, including depreciation, amortisation, impairment losses and write-downs, are also recognised in the income statement.

Assets are recognised in the balance sheet when it is probable that future economic benefits will flow to the company, and the value of such assets can be measured reliably. Liabilities are recognised in the balance sheet when it is probable that future economic benefits will flow from the company, and the value of such liabilities can be measured reliably. On initial recognition, assets and liabilities are measured at cost. Subsequently, assets and liabilities are measured as described for each item below.

On recognition and measurement, account is taken of foreseeable losses and risks arising before the date at which the annual report is presented and proving or disproving matters arising on or before the balance sheet date.

</e:DescriptionOfGeneralMattersRelatedToRecognitionMeasurementAndChangesInAccountingPolicies>
  <e:DescriptionOfMethodsOfForeignCurrencies contextRef="c1" xml:lang="en">The annual report is presented in Danish kroner (DKK).

On initial recognition, transactions denominated in foreign currencies are translated using the exchange rates applicable at the transaction date. Exchange rate differences between the exchange rate applicable at the transaction date and the exchange rate at the date of payment are recognised in the income statement as a financial item. Receivables, payables and other monetary items denominated in foreign currencies are translated using the exchange rates applicable at the balance sheet date. The difference between the exchange rate applicable at the balance sheet date and at the date at which the receivable or payable arose or was recognised in the latest annual report is recognised under financial income or expenses in the income statement. Fixed assets, inventories and other non-monetary assets acquired in foreign currencies are translated using historical exchange rates.
</e:DescriptionOfMethodsOfForeignCurrencies>
  <e:DescriptionOfMethodsOfLeases contextRef="c1" xml:lang="en">Leases relating to assets where the company has substantially all the risks and benefits incidental to the ownership of the asset (finance leases) are recognised in the balance sheet. On initial recognition, assets held under finance leases and related lease commitments are measured at the lower of the fair value of the leased asset and the present value of future lease payments. Subsequently, assets held under finance leases are treated like other similar assets.

Lease commitments relating to assets held under finance leases are recognised in the balance sheet as payables. Subsequent to initial recognition, lease commitments are measured at amortised cost according to which the interest element of the lease payment is recognised in the income statement over the lease term.

Lease payments relating to operating leases are recognised in the income statement on a straight-line basis over the lease term.

</e:DescriptionOfMethodsOfLeases>
  <e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfGrossProfitLoss contextRef="c1" xml:lang="en">Gross loss comprises revenue, other operating income and cost of sales and other external expenses.

</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfGrossProfitLoss>
  <e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfRevenue contextRef="c1" xml:lang="en">Income from the sale of goods is recognised in the income statement if delivery has taken place and the risk has passed to the buyer before the end of the financial year and where the selling price can be determined reliably and is expected to be paid. Revenue is measured at fair value and is determined exclusive of VAT and other taxes collected on behalf of third parties and less discounts.

</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfRevenue>
  <e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfOtherOperatingIncome contextRef="c1" xml:lang="en">Other operating income comprises income of a secondary nature in relation to the enterprise’s activities, including rental income, negative goodwill and gains on the sale of intangible assets and property, plant and equipment.

</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfOtherOperatingIncome>
  <e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfCostOfSales contextRef="c1" xml:lang="en">Cost of sales comprises cost of sales for the year measured at cost plus any changes in inventories, including write-downs to the extent that these do not exceed normal write-downs.

</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfCostOfSales>
  <e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfExternalExpenses contextRef="c1" xml:lang="en">Other external expenses comprise costs relating to distribution, sales and advertising and administration, premises and bad debts to the extent that these do not exceed normal write-downs.

</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfExternalExpenses>
  <e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfEmployeeBenefitExpense contextRef="c1" xml:lang="en">Staff costs comprise wages and salaries as well as other staff-related costs.


Share-based payments
Employees receive remuneration in the form of share-based payments, whereby employees render services as consideration for shares (equity-settled transactions). The cost of equity-settled transactions is determined by the fair value at the date when the grant is made using an appropriate valuation model.

That cost is recognised in employee benefits expense, together with a corresponding increase in equity, over the period in which the service are fulfilled (the vesting period). The cumulative expense recognised for equity-settled transactions at each reporting date until the vesting date reflects the extent to which the vesting period has expired and the best estimate of the number of equity instruments that will ultimately vest.


</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfEmployeeBenefitExpense>
  <e:DescriptionOfMethodsOfImpairmentLossesAndDepreciation contextRef="c1" xml:lang="en">The depreciation of property, plant and equipment aim at systematic depreciation over the expected useful lives of the assets. Assets are depreciated according to the straight-line method based on the following expected useful lives and residual values:

The basis of depreciation is the cost of the asset less the expected residual value at the end of the useful life. Moreover, the basis of depreciation is reduced by any impairment losses. The useful life and residual value are determined when the asset is ready for use and reassessed annually.

Property, plant and equipment are impaired in accordance with the accounting policies referred to in the ‘Impairment losses on fixed assets’ section.

</e:DescriptionOfMethodsOfImpairmentLossesAndDepreciation>
  <e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfIncomeAndExpensesFromInvestmentsInGroupEnterprisesAndAssociates contextRef="c1" xml:lang="en">For equity investments in equity investments in subsidiaries, measured using the equity method, the share of the enterprises’ profit or loss is recognised in the income statement after elimination of unrealised intercompany profits and losses and less any goodwill amortisation and impairment losses. 

Income from equity investments in equity investments in subsidiaries also comprises gains and losses on the sale of equity investments.

</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfIncomeAndExpensesFromInvestmentsInGroupEnterprisesAndAssociates>
  <e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfFinanceIncomeAndExpenses contextRef="c1" xml:lang="en">Interest income and interest expenses, the interest element of finance lease payments, foreign exchange gains and losses on transactions denominated in foreign currencies etc. are recognised in other net financials.

</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfFinanceIncomeAndExpenses>
  <e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfTaxExpenses contextRef="c1" xml:lang="en">The current and deferred tax for the year is recognised in the income statement as tax on the profit/loss for the year with the portion attributable to the profit/loss for the year, and directly in equity with the portion attributable to amounts recognised directly in equity.

</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfTaxExpenses>
  <e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfPropertyPlantAndEquipment contextRef="c1" xml:lang="en">Property, plant and equipment comprise leasehold improvements, plant and machinery as well as other fixtures and fittings, tools and equipment.

Property, plant and equipment are measured in the balance sheet at cost less accumulated depreciation and impairment losses. 

Cost comprises the purchase price and expenses resulting directly from the purchase until the asset is ready for use. Interest on loans arranged to finance production is not included in the cost.

Property, plant and equipment are depreciated using the straight-line method based on useful lives and residual values, which are stated in the ‘Depreciation and impairment losses' section.

Property, plant and equipment under construction
Property, plant and equipment under construction are measured at cost. Costs incurred on property, plant and equipment under construction are transferred to the relevant asset category when the asset is ready for use.

Gains and losses on the disposal of property, plant and equipment
Gains and losses on the disposal of property, plant and equipment are determined as the difference between the selling price, if any, less selling costs and the carrying amount at the date of disposal less any costs of disposal.

</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfPropertyPlantAndEquipment>
  <e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisForInvestmentsInSubsidiariesAndAssociates contextRef="c1" xml:lang="en">Equity investments in subsidiaries are recognised and measured according to the equity method. For equity investments in subsidiaries, the equity method is considered a measurement method.

On initial recognition, equity investments measured according to the equity method are measured at cost. Transaction costs directly attributable to the acquisition are recognised in the cost of equity investments. 

Under subsequent recognition and measurement of equity investments according to the equity method, equity investments are measured at the proportionate share of the enterprises' equity value, determined according to the accounting policies of the parent, adjusted for the remaining value of goodwill and gains and losses on transactions with the enterprises in question. Equity investments, where information for recognition according to the equity method is not known, are measured at cost.

Equity investments with a negative carrying amount are measured at DKK 0. Receivables that are considered part of the combined investment in the enterprises in question are impaired by any remaining negative equity value. Other receivables from such enterprises are impaired to the extent that such receivables are considered uncollectible. Provisions to cover the remaining negative equity value are recognised to the extent that the company has a legal or constructive obligation to cover the liabilities of the enterprise in question.

Gains or losses on disposal of equity investments are determined as the difference between the disposal consideration and the carrying amount of net assets at the time of sale, including non-amortised goodwill, as well as the expected costs of divestment or discontinuation. Gains and losses are recognised in the income statement under income from equity investments.

</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisForInvestmentsInSubsidiariesAndAssociates>
  <e:DescriptionOfMethodsOfAmortisationOfNoncurrentAssets contextRef="c1" xml:lang="en">The carrying amount of fixed assets which are not measured at fair value is assessed annually for indications of impairment over and above what is reflected in depreciation.

If the company's realised return on an asset or a group of assets is lower than expected, this is considered an indication of impairment.

If there are indications of impairment, an impairment test is conducted of individual assets or groups of assets.

The assets or groups of assets are impaired to the lower of recoverable amount and carrying amount.

The higher of net selling price and value in use is used as the recoverable amount. The value in use is determined as the present value of expected net cash flows from the use of the asset or group of assets as well as expected net cash flows from the sale of the asset or group of assets after the expiry of their useful lives.

Impairment losses are reversed when the reasons for the impairment no longer exist. 

</e:DescriptionOfMethodsOfAmortisationOfNoncurrentAssets>
  <e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfInventories contextRef="c1" xml:lang="en">Inventories are measured at cost calculated according to the FIFO-method. Inventories are written down to the lower of cost and net realisable value.

The cost of raw materials and consumables as well as goods for resale is determined as purchase prices plus expenses resulting directly from the purchase.

The net realisable value of inventories is determined as the selling price less costs of completion and costs necessary to make the sale and is determined taking into account marketability, obsolescence and the expected development in the selling price.

</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfInventories>
  <e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfReceivables contextRef="c1" xml:lang="en">Receivables are measured at amortised cost, which usually corresponds to the nominal value, less write-downs for bad debts.

Write-downs for bad debts are determined based on an individual assessment of each receivable if there is no objective evidence of individual impairment of a receivable.
Deposits recognised under assets comprise deposits paid to the lessor under leases entered into by the company.

</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfReceivables>
  <e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfDeferredIncomeAssets contextRef="c1" xml:lang="en">Prepayments recognised under assets comprise costs incurred in respect of subsequent financial years.

</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfDeferredIncomeAssets>
  <e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfCashAndCashEquivalents contextRef="c1" xml:lang="en">Cash includes deposits in bank account.</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfCashAndCashEquivalents>
  <e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfEquity contextRef="c1" xml:lang="en">The net revaluation of equity investments measured according to the equity method is recognized in the net revaluation reserve in equity according to the equity method to the extent that the carrying amount exceeds the cost.

</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfEquity>
  <e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfProvisions contextRef="c1" xml:lang="en">Other provisions comprise expected expenses incidental to taking back expired products and are recognised when the company has a legal or constructive obligation at the balance sheet date and it is probable that such obligation will draw on the financial resources of the company. Provisions are measured at net realisable value or fair value if the provision is expected to be settled over the longer term.

</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfProvisions>
  <e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfTaxPayablesAndDeferredTax contextRef="c1" xml:lang="en">Current tax payable and receivable is recognised in the balance sheet as tax computed on the basis of the taxable income for the year, adjusted for tax paid on account.

Deferred tax liabilities and tax assets are recognised on the basis of all temporary differences between the carrying amounts and tax bases of assets and liabilities. However, deferred tax is not recognised on temporary differences relating to goodwill which is non-amortisable for tax purposes and other items where temporary differences, except for acquisitions, have arisen at the date of acquisition without affecting the net profit or loss for the year or the taxable income. In cases where the tax value can be determined according to different taxation rules, deferred tax is measured on the basis of management’s intended use of the asset or settlement of the liability.
Deferred tax assets are recognised, following an assessment, at the expected realisable value through offsetting against deferred tax liabilities or elimination in tax on future earnings.

Deferred tax is measured on the basis of the tax rules and at the tax rates which, according to the legislation in force at the balance sheet date, will be applicable when the deferred tax is expected to crystallise as current tax.

</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfTaxPayablesAndDeferredTax>
  <e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfLiabilitiesOtherThanProvisions contextRef="c1" xml:lang="en">Convertible debt instruments are issued on terms that entitle the lender to convert the loan into equity interests in the company.

Long-term payables are measured at cost at the time of contracting such liabilities (raising of the loan). The payables are subsequently measured at amortised cost where capital losses and loan expenses are recognised in the income statement as a financial expense over the term of the payable on the basis of the calculated effective interest rate in force at the time of contracting the liability.

Short-term payables are measured at amortised cost, normally corresponding to the nominal value of such payables.

</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfLiabilitiesOtherThanProvisions>
  <e:DescriptionMethodsOfRecognitionAndMeasurementBasisForCashFlowsStatement contextRef="c1" xml:lang="en">The cash flow statement is prepared using the indirect method, showing cash flows from operating, investing and financing activities as well as cash and cash equivalents at the beginning and end of the year.

Cash flows from operating activities comprise the net profit or loss for the year, adjusted for non-cash operating items, income tax paid and changes in working capital.

Cash flows from investing activities comprise payments in connection with the acquisition and divestment of companies and financial assets as well as the purchase, development, improvement and sale of intangible assets and property, plant and equipment.

Cash flows from financing activities comprise changes in the company's share capital and associated costs and financing from and dividends paid to shareholders as well as the arrangement and repayment of long-term payables. Cash flows from financing activities also comprise finance lease payments.
</e:DescriptionMethodsOfRecognitionAndMeasurementBasisForCashFlowsStatement>
  <e:ExplanationOfEntitysDefinitionOfCashAndCashEquivalents contextRef="c1" xml:lang="en">Cash and cash equivalents at the beginning and end of the year comprise cash.
</e:ExplanationOfEntitysDefinitionOfCashAndCashEquivalents>
  <h:InformationOnCalculationOfKeyFiguresAndFinancialRatios contextRef="c1" xml:lang="en">Ratios definitions
EBITA:
Operating profit plus amortisation and im-pairment losses on goodwill.


Solidity (%):
Equity, end of year x 100
Total assets


Result per share:
Profit/loss for the year divided by average number of shares

</h:InformationOnCalculationOfKeyFiguresAndFinancialRatios>
  <e:StatementOfChangesInEquity contextRef="c1" xml:lang="en">Figures in DKK
Share capital
Retained earnings
Total equity


Statement of changes in equity for 01.01.21 - 31.12.21

Balance as at 01.01.21
934,090
51,636,473
52,570,563
Share-based payments
0
404,471
404,471
Net profit/loss for the year
0
-12,732,465
-12,732,465


Balance as at 31.12.21
934,090
39,308,479
40,242,569


Statement of changes in equity for 01.01.22 - 31.12.22

Balance as at 01.01.22
934,090
39,308,479
40,242,569
Share-based payments
0
203,343
203,343
Net profit/loss for the year
0
-16,303,170
-16,303,170


Balance as at 31.12.22
934,090
23,208,652
24,142,742
</e:StatementOfChangesInEquity>
  <e:DisclosureOfUncertaintiesRelatingToGoingConcern contextRef="c1" xml:lang="en">As of 31 December 2022, Stenocare has loans of DKK 4,8 million which fall due on 31 March 2023 and convertible loans of DKK 3,5 million which fall due on 1 January 2024. After year end, Management has prolonged loans of DKK 4,8 million to fall due on 30 June 2023. In order to secure cash flows to continue operations in accordance with the approved budget for 2023 and for settlement of current loan arrangements, Stenocare will raise funding  of approx. DKK 15-17 million in 2023. Management has together with an external advisor initiated plans to secure the funding required.

The Financial Statements are prepared under the assumption that the funding and refinancing will be solved, and therefore prepared on a going concern basis. However, this also indicates that a material uncertainty exists that may cast significant doubt on the Company’s ability to continue as a going concern.


</e:DisclosureOfUncertaintiesRelatingToGoingConcern>
  <e:DisclosureOfAnyUncertaintyConnectedWithRecognitionOrMeasurement contextRef="c1" xml:lang="en">In the financial statements for 2022, it is important to note the following uncertainty as regards recognition and measurement as it has had a significant influence on the assets and liabilities recognised in the financial statements:

STENOCARE A/S is operating under a four-year trial program, enabling all Danish physicians to prescribe cannabis for medical use. The trial program has been prolonged by the Danish Parliament for an additional 4 years to 31 December 2025. Furthermore, the Danish Parliament passed a law to permanently legalise the cultivation and production of prescription-based medical cannabis in Denmark starting 2022.

The recognition and measurement of assets, liabilities, expenses, depreciation and impairments is in all material aspects under the assumption that the necessary approvals of products and production will be obtained and that the Company's licenses will not be revoked and / or upheld by relevant government bodies. Management expects such approvals to be in place in the coming years.


</e:DisclosureOfAnyUncertaintyConnectedWithRecognitionOrMeasurement>
  <e:DisclosureOfSignificantEventsOccurringAfterEndOfReportingPeriod contextRef="c1" xml:lang="en">After the end of the financial year, the maturity of loans of mDKK 4.8 has been postponed from 31 March 2023 to 30 June 2023.

Other than this, no significant events have occurred after the end of the financial year, which have a significant impact on the financial statements.


</e:DisclosureOfSignificantEventsOccurringAfterEndOfReportingPeriod>
  <e:InformationOnOperatingSegmentsAndGeographicalMarkets contextRef="c1" xml:lang="en">Revenue
4,489,581
1,575

</e:InformationOnOperatingSegmentsAndGeographicalMarkets>
  <e:InformationOnRemunerationOfManagementCategoriesAndSpecialIncentiveProgrammes contextRef="c1" xml:lang="en">Remuneration for the management:


Total remuneration for the Executive Board
804,000
804


Remuneration for the Board of Directors
350,000
350



Remuneration for the Executive Board and Board of Directors
1,154,000
1,154
</e:InformationOnRemunerationOfManagementCategoriesAndSpecialIncentiveProgrammes>
  <e:DisclosureOfEmployeeBenefitsExpense contextRef="c1" xml:lang="en">Expense arising from equity-settled share-based payment transactions amount in 2022 to DKK 203,343 (2021: DKK 404k).</e:DisclosureOfEmployeeBenefitsExpense>
  <e:DisclosureOfPropertyPlantAndEquipment contextRef="c1" xml:lang="en">6. Property, plant and equipment

Figures in DKK
Leasehold improvements
Plant and machinery
Other fixtures and fittings, tools and equipment


Cost as at 01.01.22
1,119,359
27,688,322
686,488
Additions during the year
707,035
0
228,831


Cost as at 31.12.22
1,826,394
27,688,322
915,319


Depreciation and impairment losses as at 01.01.22
-114,556
-852,022
-170,486
Depreciation during the year
-318,128
-2,811,456
-183,067


Depreciation and impairment losses as at 31.12.22
-432,684
-3,663,478
-353,553


Carrying amount as at 31.12.22
1,393,710
24,024,844
561,766


Carrying amount of assets held under finance leases as at 31.12.22
1,267,960
0
427,184




</e:DisclosureOfPropertyPlantAndEquipment>
  <e:DisclosureOfInvestments contextRef="c1" xml:lang="en">7. Equity investments in group enterprises

Figures in DKK
Equity investments in group enterprises


Cost as at 01.01.22
7


Cost as at 31.12.22
7


Depreciation and impairment losses as at 01.01.22
-7
Net profit/loss from equity investments
-82,262
Negative equity value impaired in receivables
82,262


Depreciation and impairment losses as at 31.12.22
-7


Carrying amount as at 31.12.22
0


Name and registered office:
Ownership interest


Subsidiaries:

STENOCARE Ireland Ltd., Ireland
100




</e:DisclosureOfInvestments>
  <e:DisclosureOfProvisionsForDeferredTax contextRef="c1" xml:lang="en">31.12.22
31.12.21

DKK
DKK '000

9. Deferred tax

Provisions for deferred tax as at 01.01.22
1,377,398
1,213

Deferred tax recognised in the income statement
-20,278
165



Provisions for deferred tax as at 31.12.22
1,357,120
1,378


Deferred tax is distributed as below:

Property, plant and equipment
-2,219,025
-882

Receivables
10,495
11

Provisions
231,660
69

Liabilities
493,329
273

Tax losses
2,840,661
1,907



Total
1,357,120
1,378


As at 31.12.22, the company has recognised a deferred tax asset of DKK 1,357k. The total tax losses caried forward amounts to DKK 41,836k, corresponding to a deffered tax asset value of DKK 9,204k. The recognised deffered tax asset related to tax losses caried forward amounts to DKK 2,841k, corresponding to 30% of the total tax losses caried forward and is recognised on the basis of expectations of positive operating results for the coming years.



</e:DisclosureOfProvisionsForDeferredTax>
  <e:InformationOnSpecificPrerequisitesRegardingTaxAssets contextRef="c1" xml:lang="en">As at 31.12.22, the company has recognised a deferred tax asset of DKK 1,357k. The total tax losses caried forward amounts to DKK 41,836k, corresponding to a deffered tax asset value of DKK 9,204k. The recognised deffered tax asset related to tax losses caried forward amounts to DKK 2,841k, corresponding to 30% of the total tax losses caried forward and is recognised on the basis of expectations of positive operating results for the coming years.</e:InformationOnSpecificPrerequisitesRegardingTaxAssets>
  <e:ExplanationOfPrepayments contextRef="c1" xml:lang="en">31.12.22
31.12.21

DKK
DKK '000

10. Prepayments

Prepaid expenses
309,028
153



Total
309,028
153




</e:ExplanationOfPrepayments>
  <e:DisclosureOfOtherProvisions contextRef="c1" xml:lang="en">12. Other provisions

Figures in DKK
Other provisions


Provisions as at 01.01.22
315,000
Applied during the year
-315,000
Provisions during the year
1,053,000


Provisions as at 31.12.22
1,053,000



31.12.22
31.12.21

DKK
DKK '000


Other provisions are expected to be distributed as follows:

Current liabilities
1,053,000
315



Total
1,053,000
315


Other provisions comprise provisions to return of expired products. 



</e:DisclosureOfOtherProvisions>
  <e:DisclosureOfDeferredIncome contextRef="c1" xml:lang="en">31.12.22
31.12.21

DKK
DKK '000

14. Other payables

Bridge loan
5,686,124
0

Other payables
499,605
947



Total
6,185,729
947




</e:DisclosureOfDeferredIncome>
  <e:DisclosureOfContingentLiabilities contextRef="c1" xml:lang="en">Lease commitments
The company has concluded lease agreements with terms to maturity of 97 months and leasepayments of DKK 139k. The total lease commitment amounts to DKK 13,500k.


</e:DisclosureOfContingentLiabilities>
  <e:InformationOnRelatedEntities contextRef="c1" xml:lang="en">Related party transactions are not disclosed, as all transactions are entered into in the ordinary course of business at arms’ length.
Remuneration for the management is specified in note 2. Staff costs.


</e:InformationOnRelatedEntities>
  <!--Aktuelle periode enkelt selskab-->
  <xbrli:context id="c1">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.dcca.dk/cvr">39024705</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2022-01-01</xbrli:startDate>
      <xbrli:endDate>2022-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <!--HTAL aar2-->
  <xbrli:context id="c10">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.dcca.dk/cvr">39024705</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2021-01-01</xbrli:startDate>
      <xbrli:endDate>2021-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <!--HTAL aar3-->
  <xbrli:context id="c12">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.dcca.dk/cvr">39024705</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2022-01-01</xbrli:startDate>
      <xbrli:endDate>2022-12-31</xbrli:endDate>
    </xbrli:period>
    <xbrli:scenario>
      <xbrldi:explicitMember dimension="d:RetrospectiveInformationDimension">d:TwoYearsAgoMember</xbrldi:explicitMember>
    </xbrli:scenario>
  </xbrli:context>
  <!--HTAL ultimo aar3-->
  <xbrli:context id="c14">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.dcca.dk/cvr">39024705</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2022-12-31</xbrli:instant>
    </xbrli:period>
    <xbrli:scenario>
      <xbrldi:explicitMember dimension="d:RetrospectiveInformationDimension">d:TwoYearsAgoMember</xbrldi:explicitMember>
    </xbrli:scenario>
  </xbrli:context>
  <!--HTAL aar4-->
  <xbrli:context id="c15">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.dcca.dk/cvr">39024705</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2022-01-01</xbrli:startDate>
      <xbrli:endDate>2022-12-31</xbrli:endDate>
    </xbrli:period>
    <xbrli:scenario>
      <xbrldi:explicitMember dimension="d:RetrospectiveInformationDimension">d:ThreeYearsAgoMember</xbrldi:explicitMember>
    </xbrli:scenario>
  </xbrli:context>
  <!--HTAL ultimo aar4-->
  <xbrli:context id="c17">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.dcca.dk/cvr">39024705</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2022-12-31</xbrli:instant>
    </xbrli:period>
    <xbrli:scenario>
      <xbrldi:explicitMember dimension="d:RetrospectiveInformationDimension">d:ThreeYearsAgoMember</xbrldi:explicitMember>
    </xbrli:scenario>
  </xbrli:context>
  <!--HTAL aar5-->
  <xbrli:context id="c18">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.dcca.dk/cvr">39024705</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2022-01-01</xbrli:startDate>
      <xbrli:endDate>2022-12-31</xbrli:endDate>
    </xbrli:period>
    <xbrli:scenario>
      <xbrldi:explicitMember dimension="d:RetrospectiveInformationDimension">d:FourYearsAgoMember</xbrldi:explicitMember>
    </xbrli:scenario>
  </xbrli:context>
  <!--HTAL ultimo aar5-->
  <xbrli:context id="c20">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.dcca.dk/cvr">39024705</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2022-12-31</xbrli:instant>
    </xbrli:period>
    <xbrli:scenario>
      <xbrldi:explicitMember dimension="d:RetrospectiveInformationDimension">d:FourYearsAgoMember</xbrldi:explicitMember>
    </xbrli:scenario>
  </xbrli:context>
  <!--Overfoert resultat aktuel i aaret-->
  <xbrli:context id="c40">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.dcca.dk/cvr">39024705</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2022-01-01</xbrli:startDate>
      <xbrli:endDate>2022-12-31</xbrli:endDate>
    </xbrli:period>
    <xbrli:scenario>
      <xbrldi:explicitMember dimension="e:ResultDistributionDimension">e:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:scenario>
  </xbrli:context>
  <!--Overfoert resultat forrige i aaret-->
  <xbrli:context id="c41">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.dcca.dk/cvr">39024705</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2021-01-01</xbrli:startDate>
      <xbrli:endDate>2021-12-31</xbrli:endDate>
    </xbrli:period>
    <xbrli:scenario>
      <xbrldi:explicitMember dimension="e:ResultDistributionDimension">e:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:scenario>
  </xbrli:context>
  <!--Slutdato forrige periode enkelt selskab-->
  <xbrli:context id="c44">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.dcca.dk/cvr">39024705</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2021-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <!--Slutdato aktuelle periode enkelt selskab-->
  <xbrli:context id="c45">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.dcca.dk/cvr">39024705</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2022-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <!--Kapandele tilknyttede aktuel primo-->
  <xbrli:context id="c46">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.dcca.dk/cvr">39024705</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2022-01-01</xbrli:instant>
    </xbrli:period>
    <xbrli:scenario>
      <xbrldi:explicitMember dimension="e:ClassesOfInvestmentsDimension">e:InvestmentsInGroupEnterprisesMember</xbrldi:explicitMember>
    </xbrli:scenario>
  </xbrli:context>
  <!--Kapandele tilknyttede aktuel i aaret-->
  <xbrli:context id="c48">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.dcca.dk/cvr">39024705</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2022-01-01</xbrli:startDate>
      <xbrli:endDate>2022-12-31</xbrli:endDate>
    </xbrli:period>
    <xbrli:scenario>
      <xbrldi:explicitMember dimension="e:ClassesOfInvestmentsDimension">e:InvestmentsInGroupEnterprisesMember</xbrldi:explicitMember>
    </xbrli:scenario>
  </xbrli:context>
  <!--Kapandele tilknyttede aktuel ultimo-->
  <xbrli:context id="c50">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.dcca.dk/cvr">39024705</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2022-12-31</xbrli:instant>
    </xbrli:period>
    <xbrli:scenario>
      <xbrldi:explicitMember dimension="e:ClassesOfInvestmentsDimension">e:InvestmentsInGroupEnterprisesMember</xbrldi:explicitMember>
    </xbrli:scenario>
  </xbrli:context>
  <!--BOARD1-->
  <xbrli:context id="c58">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.dcca.dk/cvr">39024705</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2022-01-01</xbrli:startDate>
      <xbrli:endDate>2022-12-31</xbrli:endDate>
    </xbrli:period>
    <xbrli:scenario>
      <xbrldi:typedMember dimension="d:IdentificationOfMemberOfSupervisoryBoardDimension">
        <d:memberOfBoardIdentifier>1</d:memberOfBoardIdentifier>
      </xbrldi:typedMember>
    </xbrli:scenario>
  </xbrli:context>
  <!--BOARD2-->
  <xbrli:context id="c59">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.dcca.dk/cvr">39024705</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2022-01-01</xbrli:startDate>
      <xbrli:endDate>2022-12-31</xbrli:endDate>
    </xbrli:period>
    <xbrli:scenario>
      <xbrldi:typedMember dimension="d:IdentificationOfMemberOfSupervisoryBoardDimension">
        <d:memberOfBoardIdentifier>2</d:memberOfBoardIdentifier>
      </xbrldi:typedMember>
    </xbrli:scenario>
  </xbrli:context>
  <!--BOARD3-->
  <xbrli:context id="c60">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.dcca.dk/cvr">39024705</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2022-01-01</xbrli:startDate>
      <xbrli:endDate>2022-12-31</xbrli:endDate>
    </xbrli:period>
    <xbrli:scenario>
      <xbrldi:typedMember dimension="d:IdentificationOfMemberOfSupervisoryBoardDimension">
        <d:memberOfBoardIdentifier>3</d:memberOfBoardIdentifier>
      </xbrldi:typedMember>
    </xbrli:scenario>
  </xbrli:context>
  <!--BOARD4-->
  <xbrli:context id="c61">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.dcca.dk/cvr">39024705</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2022-01-01</xbrli:startDate>
      <xbrli:endDate>2022-12-31</xbrli:endDate>
    </xbrli:period>
    <xbrli:scenario>
      <xbrldi:typedMember dimension="d:IdentificationOfMemberOfSupervisoryBoardDimension">
        <d:memberOfBoardIdentifier>4</d:memberOfBoardIdentifier>
      </xbrldi:typedMember>
    </xbrli:scenario>
  </xbrli:context>
  <!--CEO1-->
  <xbrli:context id="c73">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.dcca.dk/cvr">39024705</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2022-01-01</xbrli:startDate>
      <xbrli:endDate>2022-12-31</xbrli:endDate>
    </xbrli:period>
    <xbrli:scenario>
      <xbrldi:typedMember dimension="d:IdentificationOfMemberOfExecutiveBoardDimension">
        <d:memberOfBoardIdentifier>1</d:memberOfBoardIdentifier>
      </xbrldi:typedMember>
    </xbrli:scenario>
  </xbrli:context>
  <!--Virksomhedskapital aktuel ultimo-->
  <xbrli:context id="c84">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.dcca.dk/cvr">39024705</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2022-12-31</xbrli:instant>
    </xbrli:period>
    <xbrli:scenario>
      <xbrldi:explicitMember dimension="e:ClassesOfEquityDimension">e:ContributedCapitalMember</xbrldi:explicitMember>
    </xbrli:scenario>
  </xbrli:context>
  <!--Overfort res aktuel i aaret-->
  <xbrli:context id="c101">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.dcca.dk/cvr">39024705</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2022-01-01</xbrli:startDate>
      <xbrli:endDate>2022-12-31</xbrli:endDate>
    </xbrli:period>
    <xbrli:scenario>
      <xbrldi:explicitMember dimension="e:ClassesOfEquityDimension">e:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:scenario>
  </xbrli:context>
  <!--Overfort res aktuel ultimo-->
  <xbrli:context id="c102">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.dcca.dk/cvr">39024705</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2022-12-31</xbrli:instant>
    </xbrli:period>
    <xbrli:scenario>
      <xbrldi:explicitMember dimension="e:ClassesOfEquityDimension">e:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:scenario>
  </xbrli:context>
  <!--Vederlag direktion aktuelt aar-->
  <xbrli:context id="c121">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.dcca.dk/cvr">39024705</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2022-01-01</xbrli:startDate>
      <xbrli:endDate>2022-12-31</xbrli:endDate>
    </xbrli:period>
    <xbrli:scenario>
      <xbrldi:explicitMember dimension="e:ManagementCategoryDimension">e:ManagementMember</xbrldi:explicitMember>
    </xbrli:scenario>
  </xbrli:context>
  <!--Vederlag direktion forrige aar-->
  <xbrli:context id="c122">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.dcca.dk/cvr">39024705</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2021-01-01</xbrli:startDate>
      <xbrli:endDate>2021-12-31</xbrli:endDate>
    </xbrli:period>
    <xbrli:scenario>
      <xbrldi:explicitMember dimension="e:ManagementCategoryDimension">e:ManagementMember</xbrldi:explicitMember>
    </xbrli:scenario>
  </xbrli:context>
  <!--Produktionsanlag aktuel primo-->
  <xbrli:context id="c176">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.dcca.dk/cvr">39024705</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2022-01-01</xbrli:instant>
    </xbrli:period>
    <xbrli:scenario>
      <xbrldi:explicitMember dimension="e:ClassesOfPropertyPlantAndEquipmentDimension">e:PlantAndMachineryMember</xbrldi:explicitMember>
    </xbrli:scenario>
  </xbrli:context>
  <!--Produktionsanlag aktuel i aaret-->
  <xbrli:context id="c177">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.dcca.dk/cvr">39024705</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2022-01-01</xbrli:startDate>
      <xbrli:endDate>2022-12-31</xbrli:endDate>
    </xbrli:period>
    <xbrli:scenario>
      <xbrldi:explicitMember dimension="e:ClassesOfPropertyPlantAndEquipmentDimension">e:PlantAndMachineryMember</xbrldi:explicitMember>
    </xbrli:scenario>
  </xbrli:context>
  <!--Produktionsanlag aktuel ultimo-->
  <xbrli:context id="c178">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.dcca.dk/cvr">39024705</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2022-12-31</xbrli:instant>
    </xbrli:period>
    <xbrli:scenario>
      <xbrldi:explicitMember dimension="e:ClassesOfPropertyPlantAndEquipmentDimension">e:PlantAndMachineryMember</xbrldi:explicitMember>
    </xbrli:scenario>
  </xbrli:context>
  <!--Andre anlag aktuel primo-->
  <xbrli:context id="c179">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.dcca.dk/cvr">39024705</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2022-01-01</xbrli:instant>
    </xbrli:period>
    <xbrli:scenario>
      <xbrldi:explicitMember dimension="e:ClassesOfPropertyPlantAndEquipmentDimension">e:FixturesFittingsToolsAndEquipmentMember</xbrldi:explicitMember>
    </xbrli:scenario>
  </xbrli:context>
  <!--Andre anlag aktuel i aaret-->
  <xbrli:context id="c180">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.dcca.dk/cvr">39024705</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2022-01-01</xbrli:startDate>
      <xbrli:endDate>2022-12-31</xbrli:endDate>
    </xbrli:period>
    <xbrli:scenario>
      <xbrldi:explicitMember dimension="e:ClassesOfPropertyPlantAndEquipmentDimension">e:FixturesFittingsToolsAndEquipmentMember</xbrldi:explicitMember>
    </xbrli:scenario>
  </xbrli:context>
  <!--Andre anlag aktuel ultimo-->
  <xbrli:context id="c181">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.dcca.dk/cvr">39024705</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2022-12-31</xbrli:instant>
    </xbrli:period>
    <xbrli:scenario>
      <xbrldi:explicitMember dimension="e:ClassesOfPropertyPlantAndEquipmentDimension">e:FixturesFittingsToolsAndEquipmentMember</xbrldi:explicitMember>
    </xbrli:scenario>
  </xbrli:context>
  <!--Indretning lokaler aktuel primo-->
  <xbrli:context id="c182">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.dcca.dk/cvr">39024705</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2022-01-01</xbrli:instant>
    </xbrli:period>
    <xbrli:scenario>
      <xbrldi:explicitMember dimension="e:ClassesOfPropertyPlantAndEquipmentDimension">e:LeaseholdImprovementsMember</xbrldi:explicitMember>
    </xbrli:scenario>
  </xbrli:context>
  <!--Indretning lokaler aktuel i aaret-->
  <xbrli:context id="c183">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.dcca.dk/cvr">39024705</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2022-01-01</xbrli:startDate>
      <xbrli:endDate>2022-12-31</xbrli:endDate>
    </xbrli:period>
    <xbrli:scenario>
      <xbrldi:explicitMember dimension="e:ClassesOfPropertyPlantAndEquipmentDimension">e:LeaseholdImprovementsMember</xbrldi:explicitMember>
    </xbrli:scenario>
  </xbrli:context>
  <!--Indretning lokaler aktuel ultimo-->
  <xbrli:context id="c184">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.dcca.dk/cvr">39024705</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2022-12-31</xbrli:instant>
    </xbrli:period>
    <xbrli:scenario>
      <xbrldi:explicitMember dimension="e:ClassesOfPropertyPlantAndEquipmentDimension">e:LeaseholdImprovementsMember</xbrldi:explicitMember>
    </xbrli:scenario>
  </xbrli:context>
  <!--Gald KonvGaldsbreve aktuel ultimo-->
  <xbrli:context id="c216">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.dcca.dk/cvr">39024705</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2022-12-31</xbrli:instant>
    </xbrli:period>
    <xbrli:scenario>
      <xbrldi:explicitMember dimension="e:ClassesOfLongTermLiabilitiesDimension">e:ConvertibleProfitYieldingOrDividendYieldingLongtermDebtInstrumentsMember</xbrldi:explicitMember>
    </xbrli:scenario>
  </xbrli:context>
  <!--Gald KonvGaldsbreve forrige ultimo-->
  <xbrli:context id="c217">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.dcca.dk/cvr">39024705</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2021-12-31</xbrli:instant>
    </xbrli:period>
    <xbrli:scenario>
      <xbrldi:explicitMember dimension="e:ClassesOfLongTermLiabilitiesDimension">e:ConvertibleProfitYieldingOrDividendYieldingLongtermDebtInstrumentsMember</xbrldi:explicitMember>
    </xbrli:scenario>
  </xbrli:context>
  <!--Startdato aktuelle periode enkelt selskab-->
  <xbrli:context id="c256">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.dcca.dk/cvr">39024705</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2022-01-01</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <!--Startdato forrige periode enkelt selskab-->
  <xbrli:context id="c257">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.dcca.dk/cvr">39024705</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2021-01-01</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <!--Datterselskab1-->
  <xbrli:context id="c317">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.dcca.dk/cvr">39024705</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2022-01-01</xbrli:startDate>
      <xbrli:endDate>2022-12-31</xbrli:endDate>
    </xbrli:period>
    <xbrli:scenario>
      <xbrldi:explicitMember dimension="e:TypeOfRelatedEntityDimension">e:SubsidiaryMember</xbrldi:explicitMember>
      <xbrldi:typedMember dimension="e:IdentificationOfRelatedEntityDimension">
        <e:relatedEntityIdentifier>1</e:relatedEntityIdentifier>
      </xbrldi:typedMember>
    </xbrli:scenario>
  </xbrli:context>
  <!--Datterselskab ultimo1-->
  <xbrli:context id="c318">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.dcca.dk/cvr">39024705</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2022-12-31</xbrli:instant>
    </xbrli:period>
    <xbrli:scenario>
      <xbrldi:explicitMember dimension="e:TypeOfRelatedEntityDimension">e:SubsidiaryMember</xbrldi:explicitMember>
      <xbrldi:typedMember dimension="e:IdentificationOfRelatedEntityDimension">
        <e:relatedEntityIdentifier>1</e:relatedEntityIdentifier>
      </xbrldi:typedMember>
    </xbrli:scenario>
  </xbrli:context>
  <!--HTAL VALG_1_1-->
  <xbrli:context id="c324">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.dcca.dk/cvr">39024705</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2022-01-01</xbrli:startDate>
      <xbrli:endDate>2022-12-31</xbrli:endDate>
    </xbrli:period>
    <xbrli:scenario>
      <xbrldi:typedMember dimension="h:IdentificationOfKeyFigureOrFinancialRatioDimension">
        <h:keyFigureOrFinancialRatioIdentifier>2</h:keyFigureOrFinancialRatioIdentifier>
      </xbrldi:typedMember>
    </xbrli:scenario>
  </xbrli:context>
  <!--HTAL VALG_1_2-->
  <xbrli:context id="c325">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.dcca.dk/cvr">39024705</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2022-01-01</xbrli:startDate>
      <xbrli:endDate>2022-12-31</xbrli:endDate>
    </xbrli:period>
    <xbrli:scenario>
      <xbrldi:typedMember dimension="h:IdentificationOfKeyFigureOrFinancialRatioDimension">
        <h:keyFigureOrFinancialRatioIdentifier>2</h:keyFigureOrFinancialRatioIdentifier>
      </xbrldi:typedMember>
      <xbrldi:explicitMember dimension="d:RetrospectiveInformationDimension">d:PreviousYearMember</xbrldi:explicitMember>
    </xbrli:scenario>
  </xbrli:context>
  <!--HTAL VALG_1_3-->
  <xbrli:context id="c326">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.dcca.dk/cvr">39024705</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2022-01-01</xbrli:startDate>
      <xbrli:endDate>2022-12-31</xbrli:endDate>
    </xbrli:period>
    <xbrli:scenario>
      <xbrldi:typedMember dimension="h:IdentificationOfKeyFigureOrFinancialRatioDimension">
        <h:keyFigureOrFinancialRatioIdentifier>2</h:keyFigureOrFinancialRatioIdentifier>
      </xbrldi:typedMember>
      <xbrldi:explicitMember dimension="d:RetrospectiveInformationDimension">d:TwoYearsAgoMember</xbrldi:explicitMember>
    </xbrli:scenario>
  </xbrli:context>
  <!--HTAL VALG_1_4-->
  <xbrli:context id="c327">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.dcca.dk/cvr">39024705</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2022-01-01</xbrli:startDate>
      <xbrli:endDate>2022-12-31</xbrli:endDate>
    </xbrli:period>
    <xbrli:scenario>
      <xbrldi:typedMember dimension="h:IdentificationOfKeyFigureOrFinancialRatioDimension">
        <h:keyFigureOrFinancialRatioIdentifier>2</h:keyFigureOrFinancialRatioIdentifier>
      </xbrldi:typedMember>
      <xbrldi:explicitMember dimension="d:RetrospectiveInformationDimension">d:ThreeYearsAgoMember</xbrldi:explicitMember>
    </xbrli:scenario>
  </xbrli:context>
  <!--HTAL VALG_1_5-->
  <xbrli:context id="c328">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.dcca.dk/cvr">39024705</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2022-01-01</xbrli:startDate>
      <xbrli:endDate>2022-12-31</xbrli:endDate>
    </xbrli:period>
    <xbrli:scenario>
      <xbrldi:typedMember dimension="h:IdentificationOfKeyFigureOrFinancialRatioDimension">
        <h:keyFigureOrFinancialRatioIdentifier>2</h:keyFigureOrFinancialRatioIdentifier>
      </xbrldi:typedMember>
      <xbrldi:explicitMember dimension="d:RetrospectiveInformationDimension">d:FourYearsAgoMember</xbrldi:explicitMember>
    </xbrli:scenario>
  </xbrli:context>
  <!--HTAL VALG_6_1-->
  <xbrli:context id="c349">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.dcca.dk/cvr">39024705</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2022-01-01</xbrli:startDate>
      <xbrli:endDate>2022-12-31</xbrli:endDate>
    </xbrli:period>
    <xbrli:scenario>
      <xbrldi:typedMember dimension="h:IdentificationOfKeyFigureOrFinancialRatioDimension">
        <h:keyFigureOrFinancialRatioIdentifier>7</h:keyFigureOrFinancialRatioIdentifier>
      </xbrldi:typedMember>
    </xbrli:scenario>
  </xbrli:context>
  <!--HTAL VALG_6_2-->
  <xbrli:context id="c350">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.dcca.dk/cvr">39024705</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2022-01-01</xbrli:startDate>
      <xbrli:endDate>2022-12-31</xbrli:endDate>
    </xbrli:period>
    <xbrli:scenario>
      <xbrldi:typedMember dimension="h:IdentificationOfKeyFigureOrFinancialRatioDimension">
        <h:keyFigureOrFinancialRatioIdentifier>7</h:keyFigureOrFinancialRatioIdentifier>
      </xbrldi:typedMember>
      <xbrldi:explicitMember dimension="d:RetrospectiveInformationDimension">d:PreviousYearMember</xbrldi:explicitMember>
    </xbrli:scenario>
  </xbrli:context>
  <!--HTAL VALG_6_3-->
  <xbrli:context id="c351">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.dcca.dk/cvr">39024705</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2022-01-01</xbrli:startDate>
      <xbrli:endDate>2022-12-31</xbrli:endDate>
    </xbrli:period>
    <xbrli:scenario>
      <xbrldi:typedMember dimension="h:IdentificationOfKeyFigureOrFinancialRatioDimension">
        <h:keyFigureOrFinancialRatioIdentifier>7</h:keyFigureOrFinancialRatioIdentifier>
      </xbrldi:typedMember>
      <xbrldi:explicitMember dimension="d:RetrospectiveInformationDimension">d:TwoYearsAgoMember</xbrldi:explicitMember>
    </xbrli:scenario>
  </xbrli:context>
  <!--HTAL VALG_6_4-->
  <xbrli:context id="c352">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.dcca.dk/cvr">39024705</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2022-01-01</xbrli:startDate>
      <xbrli:endDate>2022-12-31</xbrli:endDate>
    </xbrli:period>
    <xbrli:scenario>
      <xbrldi:typedMember dimension="h:IdentificationOfKeyFigureOrFinancialRatioDimension">
        <h:keyFigureOrFinancialRatioIdentifier>7</h:keyFigureOrFinancialRatioIdentifier>
      </xbrldi:typedMember>
      <xbrldi:explicitMember dimension="d:RetrospectiveInformationDimension">d:ThreeYearsAgoMember</xbrldi:explicitMember>
    </xbrli:scenario>
  </xbrli:context>
  <!--HTAL VALG_6_5-->
  <xbrli:context id="c353">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.dcca.dk/cvr">39024705</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2022-01-01</xbrli:startDate>
      <xbrli:endDate>2022-12-31</xbrli:endDate>
    </xbrli:period>
    <xbrli:scenario>
      <xbrldi:typedMember dimension="h:IdentificationOfKeyFigureOrFinancialRatioDimension">
        <h:keyFigureOrFinancialRatioIdentifier>7</h:keyFigureOrFinancialRatioIdentifier>
      </xbrldi:typedMember>
      <xbrldi:explicitMember dimension="d:RetrospectiveInformationDimension">d:FourYearsAgoMember</xbrldi:explicitMember>
    </xbrli:scenario>
  </xbrli:context>
  <!--HPCT VALG_1_1-->
  <xbrli:context id="c374">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.dcca.dk/cvr">39024705</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2022-01-01</xbrli:startDate>
      <xbrli:endDate>2022-12-31</xbrli:endDate>
    </xbrli:period>
    <xbrli:scenario>
      <xbrldi:typedMember dimension="h:IdentificationOfKeyFigureOrFinancialRatioDimension">
        <h:keyFigureOrFinancialRatioIdentifier>12</h:keyFigureOrFinancialRatioIdentifier>
      </xbrldi:typedMember>
    </xbrli:scenario>
  </xbrli:context>
  <!--HPCT VALG_1_2-->
  <xbrli:context id="c375">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.dcca.dk/cvr">39024705</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2022-01-01</xbrli:startDate>
      <xbrli:endDate>2022-12-31</xbrli:endDate>
    </xbrli:period>
    <xbrli:scenario>
      <xbrldi:typedMember dimension="h:IdentificationOfKeyFigureOrFinancialRatioDimension">
        <h:keyFigureOrFinancialRatioIdentifier>12</h:keyFigureOrFinancialRatioIdentifier>
      </xbrldi:typedMember>
      <xbrldi:explicitMember dimension="d:RetrospectiveInformationDimension">d:PreviousYearMember</xbrldi:explicitMember>
    </xbrli:scenario>
  </xbrli:context>
  <!--HPCT VALG_1_3-->
  <xbrli:context id="c376">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.dcca.dk/cvr">39024705</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2022-01-01</xbrli:startDate>
      <xbrli:endDate>2022-12-31</xbrli:endDate>
    </xbrli:period>
    <xbrli:scenario>
      <xbrldi:typedMember dimension="h:IdentificationOfKeyFigureOrFinancialRatioDimension">
        <h:keyFigureOrFinancialRatioIdentifier>12</h:keyFigureOrFinancialRatioIdentifier>
      </xbrldi:typedMember>
      <xbrldi:explicitMember dimension="d:RetrospectiveInformationDimension">d:TwoYearsAgoMember</xbrldi:explicitMember>
    </xbrli:scenario>
  </xbrli:context>
  <!--HPCT VALG_1_4-->
  <xbrli:context id="c377">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.dcca.dk/cvr">39024705</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2022-01-01</xbrli:startDate>
      <xbrli:endDate>2022-12-31</xbrli:endDate>
    </xbrli:period>
    <xbrli:scenario>
      <xbrldi:typedMember dimension="h:IdentificationOfKeyFigureOrFinancialRatioDimension">
        <h:keyFigureOrFinancialRatioIdentifier>12</h:keyFigureOrFinancialRatioIdentifier>
      </xbrldi:typedMember>
      <xbrldi:explicitMember dimension="d:RetrospectiveInformationDimension">d:ThreeYearsAgoMember</xbrldi:explicitMember>
    </xbrli:scenario>
  </xbrli:context>
  <!--HPCT VALG_1_5-->
  <xbrli:context id="c378">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.dcca.dk/cvr">39024705</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2022-01-01</xbrli:startDate>
      <xbrli:endDate>2022-12-31</xbrli:endDate>
    </xbrli:period>
    <xbrli:scenario>
      <xbrldi:typedMember dimension="h:IdentificationOfKeyFigureOrFinancialRatioDimension">
        <h:keyFigureOrFinancialRatioIdentifier>12</h:keyFigureOrFinancialRatioIdentifier>
      </xbrldi:typedMember>
      <xbrldi:explicitMember dimension="d:RetrospectiveInformationDimension">d:FourYearsAgoMember</xbrldi:explicitMember>
    </xbrli:scenario>
  </xbrli:context>
  <!--HPCT VALG_3_1-->
  <xbrli:context id="c384">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.dcca.dk/cvr">39024705</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2022-01-01</xbrli:startDate>
      <xbrli:endDate>2022-12-31</xbrli:endDate>
    </xbrli:period>
    <xbrli:scenario>
      <xbrldi:typedMember dimension="h:IdentificationOfKeyFigureOrFinancialRatioDimension">
        <h:keyFigureOrFinancialRatioIdentifier>14</h:keyFigureOrFinancialRatioIdentifier>
      </xbrldi:typedMember>
    </xbrli:scenario>
  </xbrli:context>
  <!--HPCT VALG_3_2-->
  <xbrli:context id="c385">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.dcca.dk/cvr">39024705</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2022-01-01</xbrli:startDate>
      <xbrli:endDate>2022-12-31</xbrli:endDate>
    </xbrli:period>
    <xbrli:scenario>
      <xbrldi:typedMember dimension="h:IdentificationOfKeyFigureOrFinancialRatioDimension">
        <h:keyFigureOrFinancialRatioIdentifier>14</h:keyFigureOrFinancialRatioIdentifier>
      </xbrldi:typedMember>
      <xbrldi:explicitMember dimension="d:RetrospectiveInformationDimension">d:PreviousYearMember</xbrldi:explicitMember>
    </xbrli:scenario>
  </xbrli:context>
  <!--HPCT VALG_3_3-->
  <xbrli:context id="c386">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.dcca.dk/cvr">39024705</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2022-01-01</xbrli:startDate>
      <xbrli:endDate>2022-12-31</xbrli:endDate>
    </xbrli:period>
    <xbrli:scenario>
      <xbrldi:typedMember dimension="h:IdentificationOfKeyFigureOrFinancialRatioDimension">
        <h:keyFigureOrFinancialRatioIdentifier>14</h:keyFigureOrFinancialRatioIdentifier>
      </xbrldi:typedMember>
      <xbrldi:explicitMember dimension="d:RetrospectiveInformationDimension">d:TwoYearsAgoMember</xbrldi:explicitMember>
    </xbrli:scenario>
  </xbrli:context>
  <!--HPCT VALG_3_4-->
  <xbrli:context id="c387">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.dcca.dk/cvr">39024705</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2022-01-01</xbrli:startDate>
      <xbrli:endDate>2022-12-31</xbrli:endDate>
    </xbrli:period>
    <xbrli:scenario>
      <xbrldi:typedMember dimension="h:IdentificationOfKeyFigureOrFinancialRatioDimension">
        <h:keyFigureOrFinancialRatioIdentifier>14</h:keyFigureOrFinancialRatioIdentifier>
      </xbrldi:typedMember>
      <xbrldi:explicitMember dimension="d:RetrospectiveInformationDimension">d:ThreeYearsAgoMember</xbrldi:explicitMember>
    </xbrli:scenario>
  </xbrli:context>
  <!--HPCT VALG_3_5-->
  <xbrli:context id="c388">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.dcca.dk/cvr">39024705</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2022-01-01</xbrli:startDate>
      <xbrli:endDate>2022-12-31</xbrli:endDate>
    </xbrli:period>
    <xbrli:scenario>
      <xbrldi:typedMember dimension="h:IdentificationOfKeyFigureOrFinancialRatioDimension">
        <h:keyFigureOrFinancialRatioIdentifier>14</h:keyFigureOrFinancialRatioIdentifier>
      </xbrldi:typedMember>
      <xbrldi:explicitMember dimension="d:RetrospectiveInformationDimension">d:FourYearsAgoMember</xbrldi:explicitMember>
    </xbrli:scenario>
  </xbrli:context>
  <!--HPCT VALG_8_1-->
  <xbrli:context id="c409">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.dcca.dk/cvr">39024705</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2022-01-01</xbrli:startDate>
      <xbrli:endDate>2022-12-31</xbrli:endDate>
    </xbrli:period>
    <xbrli:scenario>
      <xbrldi:typedMember dimension="h:IdentificationOfKeyFigureOrFinancialRatioDimension">
        <h:keyFigureOrFinancialRatioIdentifier>19</h:keyFigureOrFinancialRatioIdentifier>
      </xbrldi:typedMember>
    </xbrli:scenario>
  </xbrli:context>
  <!--HPCT VALG_8_2-->
  <xbrli:context id="c410">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.dcca.dk/cvr">39024705</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2022-01-01</xbrli:startDate>
      <xbrli:endDate>2022-12-31</xbrli:endDate>
    </xbrli:period>
    <xbrli:scenario>
      <xbrldi:typedMember dimension="h:IdentificationOfKeyFigureOrFinancialRatioDimension">
        <h:keyFigureOrFinancialRatioIdentifier>19</h:keyFigureOrFinancialRatioIdentifier>
      </xbrldi:typedMember>
      <xbrldi:explicitMember dimension="d:RetrospectiveInformationDimension">d:PreviousYearMember</xbrldi:explicitMember>
    </xbrli:scenario>
  </xbrli:context>
  <!--HPCT VALG_8_3-->
  <xbrli:context id="c411">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.dcca.dk/cvr">39024705</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2022-01-01</xbrli:startDate>
      <xbrli:endDate>2022-12-31</xbrli:endDate>
    </xbrli:period>
    <xbrli:scenario>
      <xbrldi:typedMember dimension="h:IdentificationOfKeyFigureOrFinancialRatioDimension">
        <h:keyFigureOrFinancialRatioIdentifier>19</h:keyFigureOrFinancialRatioIdentifier>
      </xbrldi:typedMember>
      <xbrldi:explicitMember dimension="d:RetrospectiveInformationDimension">d:TwoYearsAgoMember</xbrldi:explicitMember>
    </xbrli:scenario>
  </xbrli:context>
  <!--HPCT VALG_8_4-->
  <xbrli:context id="c412">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.dcca.dk/cvr">39024705</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2022-01-01</xbrli:startDate>
      <xbrli:endDate>2022-12-31</xbrli:endDate>
    </xbrli:period>
    <xbrli:scenario>
      <xbrldi:typedMember dimension="h:IdentificationOfKeyFigureOrFinancialRatioDimension">
        <h:keyFigureOrFinancialRatioIdentifier>19</h:keyFigureOrFinancialRatioIdentifier>
      </xbrldi:typedMember>
      <xbrldi:explicitMember dimension="d:RetrospectiveInformationDimension">d:ThreeYearsAgoMember</xbrldi:explicitMember>
    </xbrli:scenario>
  </xbrli:context>
  <!--HPCT VALG_8_5-->
  <xbrli:context id="c413">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.dcca.dk/cvr">39024705</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2022-01-01</xbrli:startDate>
      <xbrli:endDate>2022-12-31</xbrli:endDate>
    </xbrli:period>
    <xbrli:scenario>
      <xbrldi:typedMember dimension="h:IdentificationOfKeyFigureOrFinancialRatioDimension">
        <h:keyFigureOrFinancialRatioIdentifier>19</h:keyFigureOrFinancialRatioIdentifier>
      </xbrldi:typedMember>
      <xbrldi:explicitMember dimension="d:RetrospectiveInformationDimension">d:FourYearsAgoMember</xbrldi:explicitMember>
    </xbrli:scenario>
  </xbrli:context>
  <!--Virksomhedskapital forrige EKprimo-->
  <xbrli:context id="c471">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.dcca.dk/cvr">39024705</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2021-01-01</xbrli:instant>
    </xbrli:period>
    <xbrli:scenario>
      <xbrldi:explicitMember dimension="e:ClassesOfEquityDimension">e:ContributedCapitalMember</xbrldi:explicitMember>
    </xbrli:scenario>
  </xbrli:context>
  <!--Virksomhedskapital forrige EKultimo-->
  <xbrli:context id="c473">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.dcca.dk/cvr">39024705</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2021-12-31</xbrli:instant>
    </xbrli:period>
    <xbrli:scenario>
      <xbrldi:explicitMember dimension="e:ClassesOfEquityDimension">e:ContributedCapitalMember</xbrldi:explicitMember>
    </xbrli:scenario>
  </xbrli:context>
  <!--Overfort res forrige EKprimo-->
  <xbrli:context id="c491">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.dcca.dk/cvr">39024705</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2021-01-01</xbrli:instant>
    </xbrli:period>
    <xbrli:scenario>
      <xbrldi:explicitMember dimension="e:ClassesOfEquityDimension">e:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:scenario>
  </xbrli:context>
  <!--Overfort res forrige EKi aaret-->
  <xbrli:context id="c492">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.dcca.dk/cvr">39024705</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2021-01-01</xbrli:startDate>
      <xbrli:endDate>2021-12-31</xbrli:endDate>
    </xbrli:period>
    <xbrli:scenario>
      <xbrldi:explicitMember dimension="e:ClassesOfEquityDimension">e:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:scenario>
  </xbrli:context>
  <!--Overfort res forrige EKultimo-->
  <xbrli:context id="c493">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.dcca.dk/cvr">39024705</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2021-12-31</xbrli:instant>
    </xbrli:period>
    <xbrli:scenario>
      <xbrldi:explicitMember dimension="e:ClassesOfEquityDimension">e:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:scenario>
  </xbrli:context>
  <!--Produktionsanlag Leaset aktuel ultimo-->
  <xbrli:context id="c1000">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.dcca.dk/cvr">39024705</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2022-12-31</xbrli:instant>
    </xbrli:period>
    <xbrli:scenario>
      <xbrldi:explicitMember dimension="e:ClassesOfPropertyPlantAndEquipmentDimension">e:PlantAndMachineryMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="e:ClassesOfLeasingDimension">e:LeasedAssetsMember</xbrldi:explicitMember>
    </xbrli:scenario>
  </xbrli:context>
  <!--Andre anlag Leaset aktuel ultimo-->
  <xbrli:context id="c1001">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.dcca.dk/cvr">39024705</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2022-12-31</xbrli:instant>
    </xbrli:period>
    <xbrli:scenario>
      <xbrldi:explicitMember dimension="e:ClassesOfPropertyPlantAndEquipmentDimension">e:FixturesFittingsToolsAndEquipmentMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="e:ClassesOfLeasingDimension">e:LeasedAssetsMember</xbrldi:explicitMember>
    </xbrli:scenario>
  </xbrli:context>
  <!--Indretning lokaler leaset aktuel ultimo-->
  <xbrli:context id="c1004">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.dcca.dk/cvr">39024705</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2022-12-31</xbrli:instant>
    </xbrli:period>
    <xbrli:scenario>
      <xbrldi:explicitMember dimension="e:ClassesOfPropertyPlantAndEquipmentDimension">e:LeaseholdImprovementsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="e:ClassesOfLeasingDimension">e:LeasedAssetsMember</xbrldi:explicitMember>
    </xbrli:scenario>
  </xbrli:context>
  <!--Deposita aktuel primo-->
  <xbrli:context id="c1006">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.dcca.dk/cvr">39024705</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2022-01-01</xbrli:instant>
    </xbrli:period>
    <xbrli:scenario>
      <xbrldi:explicitMember dimension="e:ClassesOfInvestmentsDimension">e:DepositsLongtermInvestmentsAndReceivablesMember</xbrldi:explicitMember>
    </xbrli:scenario>
  </xbrli:context>
  <!--Deposita aktuel i aaret-->
  <xbrli:context id="c1007">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.dcca.dk/cvr">39024705</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2022-01-01</xbrli:startDate>
      <xbrli:endDate>2022-12-31</xbrli:endDate>
    </xbrli:period>
    <xbrli:scenario>
      <xbrldi:explicitMember dimension="e:ClassesOfInvestmentsDimension">e:DepositsLongtermInvestmentsAndReceivablesMember</xbrldi:explicitMember>
    </xbrli:scenario>
  </xbrli:context>
  <!--Deposita aktuel ultimo-->
  <xbrli:context id="c1008">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.dcca.dk/cvr">39024705</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2022-12-31</xbrli:instant>
    </xbrli:period>
    <xbrli:scenario>
      <xbrldi:explicitMember dimension="e:ClassesOfInvestmentsDimension">e:DepositsLongtermInvestmentsAndReceivablesMember</xbrldi:explicitMember>
    </xbrli:scenario>
  </xbrli:context>
  <!--REVISOR1-->
  <xbrli:context id="c1027">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.dcca.dk/cvr">39024705</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2022-01-01</xbrli:startDate>
      <xbrli:endDate>2022-12-31</xbrli:endDate>
    </xbrli:period>
    <xbrli:scenario>
      <xbrldi:typedMember dimension="d:IdentificationOfAuditorDimension">
        <d:auditorIdentifier>1</d:auditorIdentifier>
      </xbrldi:typedMember>
    </xbrli:scenario>
  </xbrli:context>
  <!--AktieEgnespec Besk1-->
  <xbrli:context id="c1444">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.dcca.dk/cvr">39024705</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2022-12-31</xbrli:instant>
    </xbrli:period>
    <xbrli:scenario>
      <xbrldi:typedMember dimension="e:IdentificationOfClassOfSharesDimension">
        <e:classOfSharesIdentifier>1</e:classOfSharesIdentifier>
      </xbrldi:typedMember>
    </xbrli:scenario>
  </xbrli:context>
  <!--AktieEgnespec Besk1 i aaret-->
  <xbrli:context id="c1445">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.dcca.dk/cvr">39024705</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2022-01-01</xbrli:startDate>
      <xbrli:endDate>2022-12-31</xbrli:endDate>
    </xbrli:period>
    <xbrli:scenario>
      <xbrldi:typedMember dimension="e:IdentificationOfClassOfSharesDimension">
        <e:classOfSharesIdentifier>1</e:classOfSharesIdentifier>
      </xbrldi:typedMember>
    </xbrli:scenario>
  </xbrli:context>
  <!--AktieEgnespec Besk2 i aaret-->
  <xbrli:context id="c1446">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.dcca.dk/cvr">39024705</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2022-01-01</xbrli:startDate>
      <xbrli:endDate>2022-12-31</xbrli:endDate>
    </xbrli:period>
    <xbrli:scenario>
      <xbrldi:typedMember dimension="e:IdentificationOfClassOfSharesDimension">
        <e:classOfSharesIdentifier>2</e:classOfSharesIdentifier>
      </xbrldi:typedMember>
    </xbrli:scenario>
  </xbrli:context>
  <!--AktieEgnespec Besk4 i aaret-->
  <xbrli:context id="c1448">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.dcca.dk/cvr">39024705</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2022-01-01</xbrli:startDate>
      <xbrli:endDate>2022-12-31</xbrli:endDate>
    </xbrli:period>
    <xbrli:scenario>
      <xbrldi:typedMember dimension="e:IdentificationOfClassOfSharesDimension">
        <e:classOfSharesIdentifier>4</e:classOfSharesIdentifier>
      </xbrldi:typedMember>
    </xbrli:scenario>
  </xbrli:context>
  <!--Aktier-->
  <xbrli:unit id="u1">
    <xbrli:measure>xbrli:shares</xbrli:measure>
  </xbrli:unit>
  <!--DKK 1000-->
  <xbrli:unit id="u2">
    <xbrli:measure>iso4217:DKK</xbrli:measure>
  </xbrli:unit>
  <!--Antal-->
  <xbrli:unit id="u4">
    <xbrli:measure>xbrli:pure</xbrli:measure>
  </xbrli:unit>
</xbrli:xbrl>